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ABSTRACT 
Brian Frederick Teske 
THE INTEGRATED STRESS RESPONSE 
DIRECTS CELL FATE DECISIONS IN REPSPONSE TO PERTURBATIONS IN 
PROTEIN HOMEOSTASIS 
 Disruptions of the endoplasmic reticulum (ER) cause perturbations in protein 
folding and result in a cellular condition known as ER stress.  ER stress and the 
accumulation of unfolded protein activate the unfolded protein response (UPR) which is a 
cellular attempt to remedy the toxic accumulation of unfolded proteins.  The UPR is 
implemented through three ER stress sensors PERK, ATF6, and IRE1.  Phosphorylation 
of the α-subunit of eIF2 by PERK during ER stress represses protein synthesis and also 
induces preferential translation of ATF4, a transcriptional activator of stress response 
genes.  Early UPR signaling involves translational and transcriptional changes in gene 
expression that is geared toward stress remedy.   However, prolonged ER stress that is 
not alleviated can trigger apoptosis.  This dual signaling nature of the UPR is proposed to 
mimic a ‘binary switch’ and the regulation of this switch is a key topic of this thesis.  
Adaptive gene expression aimed at balancing protein homeostasis encompasses the first 
phase of the UPR.  In this study we show that the PERK/eIF2~P/ATF4 pathway 
facilitates both the synthesis of ATF6 and trafficking of ATF6 from the ER to the Golgi 
where ATF6 is activated.  Liver-specific depletion of PERK significantly lowers 
expression of survival genes, leading to reduced expression of protein chaperones.  As a 
consequence, loss of PERK in the liver sensitizes cells to stress which ultimately leads to 
apoptosis.  Despite important roles in survival, PERK signaling is often extended to the 
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activation of other downstream transcription factors such as CHOP, a direct target of 
ATF4-mediated transcription.  Accumulation of CHOP is a hallmark of the second phase 
in the binary switch model where CHOP is shown to be required for full activation of 
apoptosis.  Here the transcription factor ATF5 is found to be induced by CHOP and that 
loss of ATF5 improves the survival of cells following changes in protein homeostasis.  
Taken together this study highlights the importance of UPR signaling in determining the 
balance between cell survival and cell death.  A topic that is important for understanding 
the more complex pathological conditions of diseases such as diabetes, cancer, and 
neurodegeneration. 
Ronald C. Wek, PhD., Chair 
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CHAPTER 1.  INTRODUCTION 
1.1 ER stress and the unfolded protein response 
The endoplasmic reticulum (ER) is a cell organelle that serves as a primary site 
for the folding and assembly of proteins, and also plays an important role in calcium 
storage, and lipid biosynthesis.  The homeostasis of proteins slated for the secretory 
pathway is controlled by translation associated with the ER, folding and modifications of 
proteins in the ER, and protein degradation of selected ER proteins.  This process is 
tightly controlled to ensure the proper synthesis and assembly of proteins destined for the 
secretory pathway.  Dysregulation in ER protein homeostasis leading to the accumulation 
of unfolded proteins can occur in response to elevated expression of secretory proteins or 
gene alterations altering protein folding, as well as perturbations in calcium levels, redox 
status, or post-translational modifications in the ER.  ER stress and accumulation of 
improperly folded proteins, a process referred to as proteotoxicity, can be an important 
contributor to the etiology of diseases including diabetes, cancer and neurodegenerative 
disorders [1-5].   
Proteotoxicity activates the ER resident transmembrane proteins ATF6, IRE1 
(ERN1), and PERK (EIF2AK3/PEK), which in turn induce the Unfolded Protein 
Response (UPR).  The UPR regulates expression of specific genes through transcriptional 
and translational mechanisms to expand the processing capacity of the ER that return it to 
homeostasis [3-5].  Specifically, changes in the translation of several transcripts upon 
phosphorylation of eIF2 by PERK facilitate a reduction in nascent polypeptide synthesis, 
thus limiting the influx of proteins into the overloaded ER [5].  Expression of ER client 
proteins is also lowered through the cleavage of their mRNAs by IRE1 [6, 7].  ATF6 is 
also reported to directly activate the synthesis of miRNA which acts to further dampen 
2 
 
the influx of ER proteins [8].  Therefore, each arm of the UPR facilitates a reduction in 
ER protein load by reducing gene expression.  This global reduction of gene expression is 
thought act as a ‘shut-off-valve’ that would prevent further organelle stress and cellular 
damage [5, 9].   
In addition to the lowered expression of genes mediated by PERK, IRE1, and 
ATF6, each of these arms of the UPR are also required for activation of the 
transcriptional master regulators ATF4, XBP1 and ATF6(N).  The details of the 
activation of the UPR will be introduced in the following sections.  Briefly, 
phosphorylation of eIF2 by PERK facilitates preferential translation of select mRNAs, 
such as ATF4, by a mechanism involving delayed translation re-initiation of inhibitory 
open reading frames (ORFs) located in the 5’-end of the encoded transcripts [10, 11].   
The endoribonuclease activity of IRE1 facilitates the cytoplasmic cleavage of XBP1 
mRNA, leading to the synthesis of the spliced and activated XBP1 (XBP1s) transcription 
factor.  ATF6 is an ER membrane bound transcription factor that upon ER stress transits 
to the Golgi where the active N-terminus, ATF6(N) is released into the cytoplasm by 
regulated intramembrane proteolysis (RIP) for subsequent transport to the nucleus 
allowing transcription of target genes.    
Initial targets of ATF4, XBP1, and ATF6 are partially overlapping and include 
genes involved in adaptive processes such as redox control, protein folding, disulfide 
bond formation, ER-Golgi trafficking, and calcium homeostasis [3, 5].  Depending on the 
extent and duration of ER stress, productive folding of proteins may not be restored, 
resulting in an inability to adapt.  This results in a second phase of the UPR, where a 
terminal unfolded protein response trigger maladaptive processes, such as premature 
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resumption in protein synthesis, inflammation, and apoptosis.  One focus of this thesis is 
defining gene regulatory networks in the UPR that decide between these adaptive and 
maladaptive cell fates.  Understanding this signaling process, which  has been referred to 
as a binary switch [12, 13], is important for identifying novel biomarkers and potential 
targets for therapeutic intervention of ER stress associated pathologies.     
This thesis investigates both the adaptive and maladaptive phases of the UPR.  
Results show that PERK mediated phosphorylation of eIF2, and the resulting enhanced 
expression of ATF4, is required for synthesis and processing of ATF6 that is needed for 
cell adaptation and survival.  The second phase or terminal UPR response that leads to 
cell death is also a key topic this thesis.  A downstream target of ATF4, CHOP can 
control cell survival in response to alterations in protein homeostasis.  We find that the 
CHOP transcription factor can induce expression of genes favoring remediation of stress 
damage, as well as those signaling apoptosis.  Interestingly, central to the changes in the 
transcriptome directed by CHOP is the finding that CHOP enhances the expression of 
many additional transcription factors that comprise additional ‘nodes’ of a transcription 
network that reinforce and amplify stress responses.  Included among these CHOP-
targeted transcription factors is ATF5, which we show is a direct downstream target of 
CHOP and ATF4.  ATF5 serves to potentiate CHOP-dependent apoptosis in response to 
inhibition of proteasome inhibition, and other disruptions of protein homeostasis.  This 
study of the second phase of the binary switch model places CHOP upstream of a 
network of transcriptional regulators and identifies new target genes of ATF5 that 
mediate the apoptotic response to stress.    
 
4 
 
1.2 Activation of the IRE1-XBP1 axis 
 IRE1 is a type I transmembrane serine/threonine protein kinase that also serves as 
an endoribonuclease.  There are two isoforms of IRE1, α and β, encoded by distinct 
genes, with the IRE1α isoform being ubiquitously expressed among tissues, and 
expression of IRE1β targeted to the digestive system [14].  Upon activation, IRE1 is 
thought to dimerize and through trans-autophosphorylation induces its endoribonuclease 
activity that facilitates cytoplasmic splicing of XBP1 transcript.  Following, the cleavage 
of the XBP1 transcript by IRE1, the joining of the exons is performed by the tRNA 
ligase, RGL1/TRL1 in yeast Saccharomyces cerevisiae [15].  Currently, it is not known 
which ligase facilitates the splicing of XBPI mRNA in mammalian cells.  This splicing 
removes a 26-nucleotide segment leading to expression of the active XBP1s basic leucine 
zipper transcription factors (bZIP) transcription factor, allowing for the newly 
synthesized XBP1 to enhance the transcription of UPR target genes involved in protein 
quality control, disulfide linkage, ERAD, and lipid synthesis [3, 14, 20]. 
Deletion of IRE1α in mice leads to embryonic lethality (e12.5) due to defects in 
placenta labyrinth vascularization involving VEGF-A [16].  When IRE1α mutants are 
supplied with a wild-type (WT) placenta, the IREα-deficient pups are born alive, which 
refutes a previous suggestion that lethality in IRE1-null animals in due to fetal liver 
hematopoetic defects [16].  Liver-specific deletion of IRE1α  also results in hepatic 
steatosis, in response to tunicamycin induced ER stress, a theme that extends to ATF6 and 
PERK knockout mice [17, 18].  Deletion of the related gene IRE1β that is predominantly 
expressed in epithelial cells of the gastrointestinal tract, sensitizes mice to chemically 
induced colitis [19].   
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XBP1 knockout mice die in utero due to fetal anemia which is a manifestation of 
liver hypoplasia and apoptosis [21].  XBP1-specific deletions in lymphatic tissues also 
revealed that XBP1 was an essential player in B-cell maturation and was the first 
transcription factor identified in terminal B-cell to plasma cell differentiation required for 
IgG secretion [14].  The finding that XBP1-deficient mice do not mirror or exacerbate 
those described for the IRE1 isoforms is consistent with the idea that IRE1 
endoribonucleases can also alter gene expression through mRNA decay, as noted above.  
Furthermore, IRE1 was reported to degrade specific miRNAs, which as a consequence 
would lead to increased expression of genes subject to repression by these small RNAs 
[22].  This thesis will describe studies showing that XBP1 expression is dependent on 
both PERK and ATF4 during ER stress, supporting the idea that there is coordinated 
expression of multiple branches of the UPR.   
 
1.3 Activation of ATF6  
ATF6 is a type II membrane-bound transcription factor that is localized to the 
ER and serves as both a sensor of ER stress and transcriptional activator of UPR target 
genes.  There are two ER stress-responsive isoforms of ATF6 designate α and β [23-25], 
with the predominant activator of UPR target genes, ATF6α (ATF6), being the primary 
focus of this study.  Deletion of ATF6α and β together in mice results in embryonic 
lethality (e 8.5), but individual deletion of either ATF6α or ATF6β does not lead to an 
overt developmental phenotype [26, 27].  ATF6α -null mice subjected to pharmacological 
induction of ER stress showed reduced expression of chaperone proteins and altered 
metabolic gene expression associated with lipid homeostasis, ultimately leading to 
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hepatic steatosis not found in the similarly treated WT animals [17, 26-28].  Central to 
the UPR dysregulation in the ATF6α -/- mice is a persistent activation of IRE1, leading to 
cytoplasmic splicing of XBP1 mRNA [4, 29, 30].   
The ATF6 exists as a transmembrane protein localized to the ER and is 
constitutively expressed during non-stress conditions.  The pool of ATF6 protein in the 
ER is continually turned over and renewed.  The C-terminus of ATF6 extends into the 
lumen of the ER and is heavily glycosylated on at least three sites containing the 
consensus motif NxS/T (Figure 1-2).  Treatment with the dolichol N-acetyl glucosamine 
transferase inhibitor, tunicamycin, prevents glycosylation of newly synthesized ATF6 
allowing for the differeniation of newly synthesized protein from previously synthesized 
ATF6 protein in the ER.  In the ER membrane, ATF6 is thought to exist as an oligomeric 
complex organized by two lumenal cysteine residues that participate in inter- and intra-
molecular disulfide bridging.  In an unstressed state, disulfide linkages between ATF6 
polypeptides are promoted due to the oxidative nature of the ER lumen.  Enzymatic or 
chemical reduction of these disulfide linkages is required for ATF6 release from the ER 
for eventual transport to Golgi for ATF6 cleavage and activation.  ATF6 is also bound 
and sequestered by the ER chaperone BIP that is thought to cover a Golgi-localization 
signal sequence (GLS) in the ER lumen, preventing trafficking of ATF6 from the ER to 
Golgi during non-stressed conditions.  Therefore ATF6 release from the ER in response 
to ER stress is thought to involve lumenal disulfide bond reduction and ATF6 release 
from BIP.   
The final step in the release of ATF6 from the ER involves packaging of ATF6 
into COPII vesicles.  This process minimally involves five proteins, the GTPase SAR1, 
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SEC23, SEC24, SEC13, and SEC31 [31].  After recruitment to the ER membrane, Sar1 
initiates coat formation by GDP to GTP exchange.  The SEC23/SEC24 heterodimeric 
complex, binds to SAR1 GTP and the second complex, SEC13/SEC31, then initiates 
membrane curvature necessary to pinch of the vesicle.  Cargo selection is thought to 
involve protein-protein interactions between SEC24 and cytosolic motifs of vesicle 
cargo, in this case ATF6.  Overexpression of dominant-negative SAR1 has been shown to 
inhibit COPII vesicle formation and block transport of ATF6 [32].   
In the Golgi, ATF6 is processed by regulated intramembrane proteolysis (RIP) 
involving consecutive cleavage by site-1-protease (S1P) and site-2-protease (S2P) 
liberating the N-terminal portion of ATF6 [3, 33, 34].  The S1P cleavage and S2P 
cleavage sites are conserved between mouse and human (Figure 1-2).  Cleavage by S1P 
removes a bulky C-terminal region in the lumen of the Golgi allowing for subsequent 
S2P access and cleavage to occur in the plane of the membrane [34].  Following cleavage 
by S2P the N-terminus of ATF6 diffuses away from the Golgi membrane and transits to 
the nucleus to activate expression of target genes.  Reduced (-SH) ATF6 monomers are 
thought to be the preferred substrate for this cleavage process and oxidized (S-S) 
monomers are proposed to be recycled back to the ER from the Golgi [35].  ATF6 is 
released as a N-terminal transcription factor, ATF6(N) which enters the nucleus and 
binds to ER stress response elements and unfolded protein response elements (ERSEs and 
UPREs) located in the promoters of UPR targeted genes [3, 26, 27, 36, 37].  This results 
in increased transcription of a network of genes, including genes encoding ER 
chaperones, such as BIP/GRP78, and components of the ER-associated degradation 
(ERAD) pathway [3, 26, 27, 37].  It should be emphasized that genes transcriptionally 
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targeted by ATF6 are necessary for an increase in ER lumen folding capacity and are 
critical for cell survival.   
As mentioned above ATF6β is not a predominant activator of UPR gene 
expression.  Although activation of ATF6β is stress-dependent, its release from the ER 
and subsequent cleavage in the Golgi in response to ER stress is delayed with respect to 
ATF6α [23].  The structure of the N-terminal trans-activation domain (TAD) also differs 
between the α and β isoforms, with the ATF6β isoform possessing an 8 amino acid insert 
in the TAD that is thought to disrupt the potency of gene activation.  Additionally, 
ATF6β has been shown to serve as a direct repressor of ATF6α mediated gene activation 
through hetero-dimerization between their bZIP domains [23].   
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Figure 1-1 Activation of ATF6 in response to ER stress.  The chaperone BIP/GRP78 
inhibits ATF6 activation by binding to the the C-terminus of ATF6 in the lumen of the 
ER.  Two cysteine residues in the lumenal domain are involved in inter- and intra- 
molecular disulfide bonding allowing for oligomerization.  Upon activation during ER 
stress, ATF6 undergoes deoligomerization and BIP release which leads to formation of 
ATF6 monomers that traffic to the Golgi.  At the Golgi, ATF6 is first processed by S1P 
cleavage, followed by regulated intermembrane proteolysis by S2P.  Intermembrane 
cleavage liberates the activated form of ATF6, designated ATF6(N), which then is 
transported to the nucleus.  ATF6(N) then binds to the promoters of  UPR target genes 
facilitating activation of transcription. 
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Figure 1-2 Sequence homology between mouse (M.m.) and human (H.s.) ATF6.  
Sequence alignment between the mouse and human orthologs of ATF6.  Sequences 
identities are shown in blue highlights, with putative N-glygosylation sites (N-X-S/T) 
labeled with a “*”.  Arrows indicate the S1P and S2P cleavage sites, and the 
transmembrane domain is shown with a black line.  The residue underlined in red at 
position 373 (H.s.) or 360 (M.m.) represents the C-terminal residue in the active 
ATF6(N) fragment that is used in overexpression studies.  Other underlined residues 
indicate amino acids required for cleavage by S1P or S2P.
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1.4 PERK dependent translation control and the integrated stress response 
The translational control arm of the UPR is directed by PERK phosphorylation 
of eIF2, a translation initiator factor that combines with GTP and delivers the initiator 
Met-tRNAi
Met
 to the translational machinery (Figure 1-3).  Phosphorylation of the α 
subunit of eIF2 at serine-51 blocks the activity of eIF2B required for the exchange of 
eIF2-GDP to the active version, eIF2-GTP [5, 38].  The subsequent reduction in protein 
synthesis conserves cellular energy and prevents further influx of nascent polypeptides 
into the ER.  Reduced protein synthesis also provides the cell ample time to implement 
the UPR reprogramming of the transcriptome.  Accompanying the repression of global 
protein synthesis, eIF2 phosphorylation (eIF2~P) also enhances the translation of select 
mRNAs, such as that encoding ATF4, a transcriptional activator of genes involved in 
metabolism, cellular redox status, and regulation of apoptosis [3, 5, 10, 39-41].    
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Figure 1-3 eIF2-GTP facilitates delivery of charged initiator tRNA to the ribosome 
during translation initiation.  eIF2 bound to GTP is required  for recruitment of the 
initiator Met-tRNAi
met
 to the 40S ribosome, leading to formation of the 43S preinitiation 
complex (PIC) that associates with the 5’-cap structure of mRNAs [38].  The small 
ribosomal complexes then scans in a 5’ to 3’ direction along the 5’-leader of the 
transcript until the appropriate initiation codon is recognized and placed in the P site.  
eIF2-GTP is hydrolyzed with the aid of eIF5 to generate eIF2-GDP, which is released 
prior to the 40S ribosomal subunit joining with the 60S ribosomal subunit.  The eIF2-
GDP is recycled to the active eIF2-GTP by the guanine nucleotide exchange factor, 
eIF2B.  The newly recycled eIF2 bound to GTP can then be used for subsequent rounds 
of translation initiation.   
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Figure 1-4 Activation of PERK during ER stress.  The luminal domain of PERK is 
bound by the ER chaperone BIP/GRP78 to maintain PERK monomers in an inactive 
state.  Upon ER stress, BIP is released from the N-terminus of PERK resulting in 
formation of PERK homodimers.  Homodimers of PERK are capable of trans-
autophosphorylation of neighboring dimers, leading to activation of the protein kinase.  
Activated PERK then phosphorylates eIF2, facilitating preferential translation of ATF4 
mRNA.   
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1.5 eIF2~P activation of ATF4 is not unique to ER stress 
In addition to ER stress, preferential translation of ATF4 occurs in response to 
diverse stress conditions that regulate three other eIF2 kinases [5, 38, 42].   For example, 
in response to starvation for amino acids, the eIF2 kinase GCN2 serves to conserve 
nutrients [42-44], while HRI insures that globin synthesis is coupled to heme availability 
in erythroid tissues [45].  The eIF2 kinase PKR participates in the anti-viral defense 
mechanism directed by interferon.  In each case, eIF2~P abruptly blocks translation 
initiation by reducing the recycling of eIF2-GDP to eIF2-GTP, while preferentially 
translating ATF4, a master transcriptional regulator of stress-related genes [2, 4, 40].  The 
idea that ATF4 is an induced downstream factor that integrates signaling from PERK and 
other eIF2 kinases has led to the designation of the eIF2~P/ATF4 pathway as the 
Integrated Stress Response (ISR) [40].   
 Early signaling in the ISR network is critical for ameliorating stress conditions, 
such as those afflicting the ER organelle, as genetic perturbations of the eIF2 kinases 
have significant medical consequences.  For example, PERK disruption leads to Wolcott-
Rallison syndrome, which is characterized by neonatal diabetes, atrophy of the exocrine 
pancreas, skeletal dysplasia, growth retardation, and hepatic complications resulting in 
morbidity [46-48].  These pathologies were recapitulated in PERK-deficient mice [49, 
50], where the molecular and cellular mechanisms have been investigated [51-54]. 
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1.6 Dephosphorylation of eIF2 
 Translation control through eIF2~P can also be regulated by protein phosphatases.  
eIF2~P is dephosphorylated by protein phosphatase type 1 (PP1c), which requires a 
targeting subunit for holoenzyme function [55].  Under non-stressed conditions, the 
CReP-PP1c complex is responsible for maintaining eIF2/eIF2~P homeostasis.  CReP is 
rapidly turned over and therefore continual synthesis of CReP is required to maintain the 
eIF2/eIF2~P balance within the cell.  As part of a feedback mechanism, there is increased 
synthesis of the PP1c targeting subunit, GADD34.  GADD34 mRNA is induced by the 
ISR pathway via ATF4/CHOP transcriptional activation and GADD34 is also 
preferentially translated by a mechanism involving eIF2~P; thus there are multiple layers 
of regulation that facilitate this negative feedback loop.  GADD34 feedback appears to be 
necessary for resumption of global protein synthesis once the transcriptome has been 
reprogrammed to alleviate stress.  However, premature resumption of protein synthesis 
by GADD34 can also lead to further ER overload and initiate a terminal ER stress 
response.  Therefore, GADD34 can have significant proapoptotic functions during 
chronic stresses [56].   
 CReP/GADD34 mediated eIF2~P dephosphorylation can be targeted 
pharmacologically with salubrinal, Sal003, and a GADD34-specific inhibitor guanabenz 
[57, 58].  These drug inhibitors elicit robust eIF2~P and activation of ATF4.  In cell 
culture experiments, removal of these inhibitors from treatment media rapidly reverses 
eIF2~P and reduces levels of ATF4 and its target genes.   
 The importance of regulation of eIF2~P can also be seen in several mouse 
models.  First, mice containing an alanine substituted for the phosphorylation site serine-
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51 in eIF2 (S51A, designated A/A mice) can be born alive, suggesting that regulation of 
translation initiation through eIF2~P is not required for embryogenesis.  However, in A/A 
mice liver gluconeogenesis was severely diminished, which is suggested to contribute to 
perinatal lethality in these animals [59].  Alternatively, hyperphosphorylation of eIF2 by 
genetic disruption of PP1c regulatory subunits CREP and GADD34 in mice leads to 
altered levels of eIF2~P, translation control, and has health consequences [56].  GADD34 
knockout mice do not appear to be developmentally different from WT mice and display 
slight resistance to ER stresses.  By comparison, CREP knockout animals are born alive 
but are of low birth weight, fail to nurse, and die in the post natal period within the first 
day of life.  Double disruption of both PP1c regulatory subunits results in embryonic 
lethality [60].   
 
1.7 Distal ISR signaling initiates maladaptive stress responses  
 It is also important to note that while the ISR serves essential adaptive functions 
in response to ER stress and other stress arrangements, perturbations in or unabated 
induction of these stress responses can contribute to morbidity.  The immediate 
downstream target of eIF2~P is the ISR master transcriptional regulator ATF4.  Genetic 
disruption of ATF4 in mice is not lethal although knockout mice display low fertility, 
fetal anemia, and developmental defects in lens formation [61].  ATF4 activates genes by 
a specific CCAAT-enhancer activating transcription factor response element (CARE) 
[62, 63].  Binding of ATF4 at these CARE elements is thought to be dynamic where the 
ATF4 transcriptional signal can be differentially modified by the association with partner 
proteins as heterodimers [62].        
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The processes by which the ISR can adversely affect cells is not well understood, 
but central to this process is the ATF4-target gene, CHOP (GADD153/DDIT3), a 
transcriptional regulator whose extended expression during stress can trigger apoptosis 
[3, 56, 64-66].  Thus the ISR pathway is often extended to include genes downstream of 
eIF2~P and ATF4, such as ATF3 and CHOP, which collectively participate in regulation 
of ISR-target genes [5, 63, 67].  CHOP is implicated in many different stress conditions 
and is central for apoptosis during selected stress conditions [2, 4, 56].  Several CHOP 
targets genes involved in the regulation of apoptosis include BCL2, ERO1, DR5, BIM and 
GADD34; however the transcription factor network regulating these genes has been 
poorly defined.    
 
1.8 Induction of the ISR network extends to ATF5  
This thesis identifies ATF5 as an important transcription factor in the ISR, which 
is downstream of CHOP and sensitizes cells to apoptosis.  ATF5 is another member of 
the ATF/CREB family of bZIP proteins.  Two alternatively spliced ATF5 transcripts 
(ATF5α/β) have been identified with distinct 5’-leaders that encode different uORF 
arrangements [68].  ATF5α is the more abundant transcript, expressed highly in liver but 
also detected in brain, heart, lung and kidney [68], and will be a focus of this study.  
ATF5 has been shown to be regulated at both the transcriptional and translation level [69, 
70] and can also be regulated post-translationally by p300 directed acetylation at lysine-
29 [71].  At the translational level, ATF5 expression is regulated by two uORFs and the 
synthesis is dependent on eIF2~P and a mechanism involving delayed ribosome 
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reiniation that was described for ATF4 [70].    ATF5β appears to be largely restricted to 
early development, and is not subject to translational control by eIF2~P. 
 
1.9 Cross-talk in the ISR network reinforces cell fate decisions  
The results in Chapter 3 of this thesis center on the early survival pathways that 
are controlled by the ISR.   As described in introductory sections 1.2 to 1.4, activation of 
ATF6, IRE1, and PERK in response to ER stress is thought to occur in parallel, but the 
timing and duration of each may differ.  Although the complete mechanistic details are 
not yet resolved, it has been proposed that the ER luminal portions of each of these 
sensory proteins can be bound and repressed by BiP [3, 72].  Accumulation of unfolded 
proteins in the ER lumen is suggested to compete with the sensory proteins for BIP 
binding, enhancing release of this ER chaperone from each ER sensor and thus leading to 
their activation [3, 72-75].  Alternatively, it has been proposed that unfolded proteins can 
directly interact with the ER sensor proteins, such as IRE1, which then facilitates 
oligomerization and activation [3, 76-79].  These models posit that activation of the 
sensory proteins in response to ER stress occurs largely by independent rather than by 
interconnected processes.  We wished to determine if the translational control arm of the 
UPR is coupled to the regulation of the transcriptional components of this stress response, 
insuring coordinate control of the transcription and translation phases of the UPR.  Our 
studies show that the PERK/eIF2~P/ATF4 pathway is required to facilitate activation of 
ATF6 in response to ER stress both in vivo and in cultured cells.  As a consequence, 
liver-specific deletion of PERK leads to enhanced apoptosis in response to ER stress, 
along with hepatic dysfunctions, features that are similar to those described for ATF6-null 
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mice.  In this model, loss of PERK mediated translational control of the UPR also 
significantly blocks the transcriptional arms, resulting in dysregulation of the UPR 
network that would ultimately contribute to disease.   
Results in Chapter 4 of this thesis investigate UPR signaling involved in 
maladaptive cell fates.  Specifically, this study focuses on defining transcription factor 
networks directed by the ISR pathway in response to perturbations in protein 
homeostasis.  Among ISR genes, CHOP is considered a central inducer of stress induced 
apoptosis [2, 56].  Several CHOP target genes have been suggested to be involved in the 
switch to apoptosis.  For example, ERO1α is involved in the formation of disulfide bonds 
in the ER lumen, a process that eventually leads to oxidative damage if accumulation of 
unfolded protein is not resolved.   As noted earlier, expression of GADD34 restores 
translation initiation, which can further exacerbate an overloaded ER and can therefore be 
viewed as maladaptive during chronic stress.  This dual nature of ISR signaling that 
involves signaling decisions between adaptive and maladaptive cell fates has been 
referred to as a “binary switch” [12, 13], A focus of this study is to define gene regulatory 
networks controlling of the switch between cell fates.  The signaling events are not well 
defined, but induction of CHOP is suggested to be a central event.  Therefore a major 
goal of Chapter 4 is to define and characterize novel transcription factors downstream of 
CHOP that may play a role in ISR signaling toward cell death.  We found that ATF5 is a 
direct downstream target of CHOP and that ATF5 serves to potentiate CHOP-dependent 
apoptosis in response to diverse stress conditions.    
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CHAPTER 2.  EXPERIMENTAL METHODS  
 This section will describe the methods used in experiments described in this 
thesis.  These experimental methods will also highlight critical considerations and useful 
tips in designing and conducting experiments analyzing the ISR and UPR.   
 
2.1 Cell Culture   
 PERK
-/-
, ATF4
-/-
, CHOP
-/-
 and A/A MEF cells, and their WT counterparts, have 
been described previously [39, 80].  MEF cells were grown in Dulbecco’s Modification 
of Eagle’s Medium (DMEM) (4.5 g/L glucose), supplemented with 1X MEM non-
essential amino acids (HyClone SH30238.01) and 50 μM β-mercaptoethanol, as 
described previously [40].  HEK293 and the mouse hepatoma cell line, HEPA1-6, were 
also cultured in DMEM (4.5 g/L glucose).   Cultured cells were treated with 2 μM 
tunicamycin,  1 μM thapsigargin, 1 μM MG132, 10 μM actinomycin D, 50 μg/ml 
cycloheximide, and 5 μg/ml brefeldin A, and 10 μM Sal003, as indicated.  Sal003 was 
added at a final concentration of 10 M, by first diluting a 10 mM stock to 100 μM in 
warm media prior to adding to the cultured cells.  Specific experimental details regarding 
pretreatments or co-treatments are provided in the figure legends.  When designing stress 
response experiments, it was important to consider the dosage and duration of stress 
exposure.  The selected concentrations were determined to be optimal for the induction of 
the UPR and ISR, or in the case of actinomycin D and cycloheximide, for repression of 
transcription or protein synthesis, respectively.  The timing of the chemical induction of 
stress response is also critical.  Transcriptional regulators of the ISR often appeared early 
in a stress time course.  For example, eIF2~P and ATF4 can be detected in cultured cells 
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within about 1-2 hours of treatment with agents that can induce ER stress, while CHOP is 
induced between 3 and 6 hours.  By contrast, measurements of apoptotic markers were 
detectable between 12 and 24 hours of stress induction.   
 
2.2 Measurement of eIF2~P and the ISR by immunoblot analyses 
Cellular lysates were prepared from cultured cells using RIPA-buffered solution 
containing 50 mM Tris-HCl (pH 7.9), 150 mM sodium chloride, 1% nonident P-40, 0.1% 
sodium dodecyl sulfate (SDS), 100 mM sodium fluoride, 17.5 mM β-glycerophosphate, 
0.5% sodium deoxycholate, and 10% glycerol that was supplemented with EDTA-free 
protease inhibitor cocktail tablet (Roche).  Protein content was determined for each 
preparation by a modified Bradford or Lowry assay, such as that offered by the Bio-Rad 
protein quantification kit for detergent lysis (cat no.  500-0114) following the 
manufacturer’s instructions.  Equal amounts of protein preparations, typically 10 to 30 
g, was prepared in 2X SDS sample buffer, heated at 95˚C, and then separated by 
electrophoresis using an SDS polyacrylamide gel.  The percentage of acrylamide for 
these gels was 7.5%, 10%, or 12% to insure linearity for the size of the measured 
proteins.  Polypeptide markers of known molecular weight were included to determine 
the size of proteins identified in the immunoblot analysis.  Proteins separated by gel 
electrophoresis were then transferred to nitrocellulose filters, and the membranes were 
then incubated in 5% (w/v) nonfat milk powder in PBS followed by incubation with 
antibody that specifically recognizes the proteins of interest.  After washing the filters to 
remove unbound antibody, secondary antibody was added (dilution 1:3000 to 1:10,000).  
The secondary antibodies contained a dye label for visualization of the target protein with 
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the Odyssey infrared imaging system (LI-COR).  Alternatively, secondary antibodies 
conjugated to horse radish peroxidase (HRP) were used for detection with an enhanced 
chemiluminescent (ECL) immunoblot protocol.   This ECL protocol used “homebrewed” 
solutions that were made fresh or in bulk and kept at 4˚C for several weeks.  For 
detection, equal volumes of solution 1 and solution 2 were mixed and applied evenly to 
the membrane filter for 1-2 minutes followed by film detection.  Solution 1 contained 100 
mM Tris-HCl (pH 8.5), 2.5 mM 3-aminophthalydrazide (Luminol; Sigma-Aldrich #A-
8511) and 0.4 mM P-coumaric acid (Sigma-Aldrich #C-9008) and Solution 2 contained 
100 mM Tris-HCl (pH 8.5) and H2O2 (stock 30%) at a final concentration of 0.02%.  
Freshly prepared solutions usually gave the more intense signal, but SuperSignal West 
Femto from Thermo Scientific (Prod #34094) was used for immunoblot analyses when 
more sensitivity was needed, such as immunoblots measuring eIF2~P.  A common 
troubleshooting practice involved the use of the more sensitive West Femto substrate 
after faint unmanageable protein bands appeared with the less sensitive ECL solutions.  
The coupled use of LI-COR and ECL immunoblot detection allowed for detection of 
multiple different proteins from a single immunoblot filter.  Thus this bypassed the need 
for multiple rounds of membrane filter stripping and also allowed for detection of 
proteins of similar size from one blot when cutting the membrane was not an option.   
  Antibodies for eIF2~P (Ser51), cleaved caspase-3, and Grp78/BiP were 
purchased from Cell Signaling Technology, total eIF2 and CHOP were purchased from 
Santa Cruz Biotechnology, and actin from Bethyl Laboratories.  Secondary antibodies 
were purchased from Jackson Laboratories.  ATF6 antibody was prepared in rabbits 
using the mouse ATF6 N-terminal amino acids 6-307 as the antigen.  ATF6 antibody was 
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used at a concentration of 1:500 in 5% milk powder in PBS.  ATF4 and ATF5 antibodes 
prepared against full-length recombinant human ATF4, were affinity purified, and used 
in immunoblot analyses.     
There are many different antibody preparations for measuring eIF2~P and ISR 
target proteins that are available commercially.  However, these commercial antibodies 
can vary in their affinity and specificity.  Even when commercial antibodies are indicated 
in publications, it is important to appreciate that the efficacy can vary between 
commercial antibody preparation, even when procuring antibodies with the same product 
number and lot number.  Establishing criteria for antibody specificity, in conjunction with 
suitable control lysate preparations, is important, especially when characterizing new 
cultured cell lines or tissue types.  The following are guidelines for antibody usage based 
on our laboratory experience.  Antibodies against eIF2~P typically worked well among 
different vertebrate protein preparations, as the sequences flanking the serine-51 are well 
conserved.  Antibody against eIF2~P was typically used at a concentration of 1:250, but 
depending on the commercial antibody preparation, dilutions often varied in the range of 
1:50 and 1:1000.  Measurements of total eIF2 were important to insure that induced 
eIF2~P was not a function of changes in the levels of the translation factor.  CHOP 
antibodies were also typically reliable and were used at a concentration range of 1:1000 
to 1:3000.  Immunoblot analyses of CHOP protein sometimes resulted in a doublet band 
that may represent CHOP phosphorylation [81].   
Immunoblot analyses measuring ATF4 protein offered the greatest technical 
hurdles.  The predicted molecular weight of ATF4 is 38 kD, but ATF4 typically migrated 
with a size between 45 to 52 kD by SDS-PAGE.  Furthermore, ATF4 often migrated as a 
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broad band in immunoblots, which upon closer inspection seemed to represent multiple 
bands that appeared to be a consequence of protein phosphorylation [5, 82-84].   
It is important not to grow cultured cells to more than 70% confluency prior to 
treatment.  Confluent growth of cultured cells is by nature a stress that can induce 
eIF2~P.  High basal eIF2~P levels in the absence of added stress agents is not an 
uncommon dilemma in experiments, and this can lead to experimental misinterpretations 
when appropriate controls are not included in the studies.  As noted above, when studying 
new stress conditions or cell types for induction of eIF2~P it is helpful to conduct a dose 
response at a fixed time point, such as 6 hours of exposure.  Once an optimum stress 
condition is determined, keeping in mind the physiological parameters for a given stress, 
this can be followed with a time course.   
 Liver tissue samples were
 
prepared for SDS-PAGE as previously described [85].  
Tissues were homogenized in 7 volumes of a solution consisting of 20mM 
 
N-2-
hydroxyethylpiperazine-N'-2-ethanesulfonic acid (pH 7.4),
 
100 mM KCl, 0.2 mM EDTA, 
2 mM EGTA, 1 mM dithiothreitol, 50 mM sodium fluoride,
 50mM β-glycerophosphate, 
0.1 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine,
 
and 0.5 mM sodium 
orthovanadate.  Following electrotransfer to nitrocellulose filter, immunoblots were 
incubated with primary and secondary antibodies, and then were visualized using 
enhanced chemiluminescence reagents (ECL) (GE Biosciences).   
To measure the half-life of ATF6(N), plasmid p913 encoding an N-terminal HA-
tagged version of ATF6 residues 1-373 (HA-ATF6-1-373) was transfected into WT or 
ATF4
-/-
 MEF cells.  After 24 hours, cells were pre-treated with 2 μM tunicamycin for 3 
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hours, or exposed to no ER stress, followed by the addition of 50 μg/ml cycloheximide.  
Cells were then incubated for up to 8 hours.   
 
2.3 Interpreting whether the observed induction of eIF2~P and the ISR results from 
ER stress 
 An observed increase in eIF2~P and the ISR is not necessarily a demonstration of 
ER stress, as many different stress conditions involving other cellular compartments can 
activate the eIF2 kinase family.  There are four strategies to ensure that an observed 
increase in eIF2~P is a consequence of ER stress.  Each offers certain advantages and 
deficiencies, which should be recognized during the design of the proposed ER stress 
experiments.  The first strategy is indirect, and involves measuring the activity of the 
UPR sensors, IRE1 or ATF6, in conjunction with eIF2~P.  These UPR sensors are 
thought to be exclusively activated by ER stress.  IRE1 facilitates cytoplasmic splicing of 
XBP1 mRNA, which then leads to synthesis of the transcription activator of UPR genes 
[86].  Splicing of XBP1 mRNA can be measured by qPCR [87, 88], and enhanced eIF2~P 
combined with spliced XBP1 mRNA gives one a degree of confidence that the underlying 
stress being studied perturbs the ER.  It is noted that there are some stresses that have 
been reported to have discordant activation or amplification of PERK and IRE1 [88-90], 
which can complicate negative experimental findings.   
Additional strategies for establishing whether a studied stress induces eIF2~P due 
to ER stress includes measuring eIF2~P in PERK
-/- 
mouse embryo fibroblast (MEF) cells, 
or specifically knocking down this eIF2 kinase using shRNA [80, 91-93].  A collection of 
MEF knockout cells have been described that are deleted for one or more of the eIF2 
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kinase genes, and significant reductions in levels of stress induced eIF2~P in PERK 
depleted cells supports the idea that there is an underlying ER stress [80].  However, it is 
noted that longer periods of ER stress exceeding 6 hours can induce eIF2~P in PERK
-/-
 
cells.  It is suggested that secondary eIF2 kinases are activated during these extended 
periods of stress.   Another related strategy is to measure the phosphorylation status of 
PERK, which is known to occur during the activation of this eIF2 kinase.  Commercial 
antibodies are available for measuring phosphorylation of PERK at the activation loop 
(threonine-980), and measuring phospho-PERK by immunoblot analysis along with total 
PERK levels is a strategy for determining whether a stress activates this ER-stress 
inducible eIF2 kinase [50, 73, 94].  It is noted that immunoblot analysis of phospho-
PERK can be problematic, as PERK is a large membrane-bound protein (~125 kD), and 
the phosphorylated version of this eIF2 kinase can migrate as several tightly packed 
bands in SDS-PAGE.  In fact the increase in migration of PERK was originally used to 
establish its phosphorylation and activation during ER stress [73, 94].  Frequently 
measures of phospho-PERK have involved first immunoprecipitating PERK, which can 
improve the sensitivity and specificity of the phospho-PERK antibody in immunoblot 
analysis [39, 50, 87].  A final strategy for establishing whether eIF2~P is a consequence 
of ER stress and activation of PERK is to carry out in vitro kinase assays using 
recombinant eIF2 substrate and immunoprecipitated PERK prepared from stressed cells 
showing enhanced eIF2~P[95].  Increased PERK eIF2 kinase activity in this in vitro 
assay would provide confidence that the studied stress condition involves ER stress and 
the UPR.    
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2.4 Animals  
 The animal study protocol was approved by the Institutional Care and Use 
Committee at the Indiana University School of Medicine-Evansville.  Mice 
homozygous for the LoxP allele of PERK (PERK
fl/fl
) were mated with transgenic mice 
heterozygous for Cre recombinase expressed from the albumin gene promoter 
(AlbCre) to create a liver-specific deletion of PERK, LsPERK-KO (AlbCre
+
, 
PERK
fl/fl
).  This mating also produced littermates that are Cre negative that express a 
WT version of PERK (AlbCre
-
, PERK
fl/fl
) [85, 96].  The LsPERK-KO mice were 
derived from a cross between C57BL/6 and 129SvE mice.  Genotyping that showed 
efficient PERK gene deletion in the LsPERK-KO livers was reported  [85], which is 
consistent with lowered eIF2~P levels in response to tunicamycin treatment.  Male 
and female adult mice (n=5-8 per treatment group), ages 3 to 6 months, were
 
individually housed in wire-bottomed cages, maintained on a 12 hour light/dark cycle, 
and provided unrestricted access to food (7017 NIH-31
 
Open Formula Mouse/Rat 
Sterilizable diet, Harlan Teklad) and water.  The key gene expression, triglyceride, 
and apoptotic findings reported in this study were similar between the male and 
female mice.  Among the assays in which n=8, there were between 4-7 males, and 
between 1-3 females.  Analysis of ATF6 activation includes independent liver samples 
prepared from at least one male and one female in each treatment group.  Mice were 
administered tunicamycin by intraperitoneal (i.p.) injection at a dose of 1 mg/kg body 
weight or an equivolume of excipient (0.3% DMSO in phosphate buffered saline) 
[97].  Mice were euthanized by decapitation at 6, 12, 24, or 36 hours after injection.  
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Dissected livers were rinsed in ice-cold PBS, weighed, and either snap-frozen in liquid 
nitrogen or fixed in 4% paraformaldehyde.   
 
2.5 Reverse Transcription and Real-Time PCR  
 Total RNA was extracted from frozen tissue using TriReagent (Molecular 
Research Center, Inc.) followed by a DNase treatment (VersaGene DNase kit, Gentra 
Systems).  To inactivate the reaction, the samples were heated to 70°C
 
for 5 min.  RNA 
samples were further purified using the RNeasy mini kit (Qiagen), yielding preparation 
with an A260/A280 ratio between 1.8 and 2.0.  The levels of the indicated mRNAs were 
determined by qPCR.  Approximately 1 μg of each of the RNA solutions was used for 
reverse transcription, which employed the High-Capacity cDNA Reverse Transcription 
Kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's 
instructions.  TaqMan Gene Expression Master Mix (Roche) and TaqMan Gene 
Expression Assays (Applied Biosystems) were used for the quantitative PCR.  
Amplification and detection were performed on the LightCycler 480 (Roche).  For 
measurement of the spliced version of the XBP1 mRNA, the forward primer 5’-
GAGTCCGCAGCAGGTG-3’ and reverse primer 5’-CTCTGGGAGTTCCTCCAGACT-
3’ were used in the qPCR.   All measurements were in triplicate and normalized to β-
actin or 18S mRNA.  Results were obtained by the comparative Ct method, and results 
were expressed as fold change with respect to the non-stressed control.  qPCR was also 
performed on RNA extracted from cultured cells.   
Total RNA was extracted from MEF cells using TriZol reagent following the 
manufactures instructions for adherent cells.  The levels of the indicated mRNAs were 
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determined by qPCR.  Approximately 1 μg of each of the RNA solutions was used for 
reverse transcription, which employed the High-Capacity cDNA Reverse Transcription 
Kit (Applied Biosystems) according to the manufacturer's instructions.  Primers for 
SYBR green detection of cDNA are listed in Table 1.  Amplification and detection were 
performed on the LightCycler 480 (Roche) or the Realplex
2
 Master Cycler (Eppendorf).  
All measurements were recorded in biological and technical triplicates and normalized to 
β-actin mRNA.   Results were obtained by the comparative Ct method, and results were 
expressed as fold change with respect to the untreated control. 
 
Table 2-1 Sequence of oligonucleotides for SYBR green based qRT-PCR. 
Primer name Sequence  
mCHOP 5’-CCTAGCTTGGCTGACAGAGG-3’ 
5’-CTGCTCCTTCTCCTTCATGC-3’ 
mATF4 5’-GCCGGTTTAAGTTGTGTGCT-3’ 
5’-CTGGATTCGAGGAATGTGCT-3’ 
mβ-Actin 5’-GTATGGAATCCTGTGGCATC-3’ 
5’-AAGCACTTGCGGTGCACGAT-3’ 
mGADD34 5’-AGGACCCCGAGATTCCTCTA-3’ 
5’-CCTGGAATCAGGGGTAAGGT-3’ 
mATF5 5’-GGCTGGCTCGTAGACTATGG-3’ 
5’CCAGAGGAAGGAGAGCTGTG-3’ 
mNOXA 5’-GACAAAGTGAATTTACGGCAGA-3’ 
5’-GGTTTCACGTTATCACAGCTCA-3’ 
mAPAF1 5’-GTTCAAAGCCGAGACAGGAG-3’ 
5’-ATTGACTTGCTCCGAGTGCT-3’ 
mTXNIP 5’-TATGTACGCCCCTGAGTTCC-‘3 
5’-GCTCACTGCACGTTGTT-3’ 
Each of these indicated genes are derived from mouse, as indicated by the “m” 
designation preceding each. 
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2.6 Histology 
  Tissues fixed in 4% paraformaldehyde were frozen and then sectioned (10 μm) 
using a cryostat.  TUNEL assays were performed according to the manufacturer’s 
instructions (Trevigen TACS 2 TdT-Blue Label in situ Apoptosis Detection kit, R&D 
Systems).  TUNEL-positive cells were measured from 3 equal sized areas per section.  
Digital images of selected areas captured at 200X were imported into Scion Image for 
Windows (Scion Corporation, Inc.), and TUNEL-positive cells were manually marked 
and counted using the counting tool.  The TUNEL-staining showed pyknotic bodies, and 
the nucleus was stained darker than the cytoplasm portion in the tissue preparations.  
Frozen sections were also stained with Oil Red O and counter stained with hematoxylin 
to visualize lipid content and tissue morphology.   
 
2.7 Triglyceride Measurements  
 Triglycerides were measured using the Triglyceride Quantification Kit from 
BioVision Research Products (Mountain View, CA) following the manufacturer’s 
instructions.  Tissue samples (~40 mg) were weighed and homogenized in 10 volumes of 
a 5% NP-40 solution.  Samples were heated to 85˚C then subjected to centrifugation at 
10,000 x g for 2 minutes at room temperature.  The resulting supernatants were diluted 
1:500 with sterile water, and a volume of 50 μl of diluted supernatant was added to 50 μl 
of reaction mix and absorbance levels were measured at 570 nm.  The absorbance of the 
standards was plotted and test sample readings were applied to the standard curve to 
calculate the triglyceride concentrations.   
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2.8 Microarray analysis  
 Microarray analysis was carried out using RNA prepared from livers obtained 
from WT and LsPERK-KO mice injected with 1 mg/kg body weight of tunicamycin or 
excipient for 6 hours, as highlighted above in the Animals section of the Experimental 
Methods.  Three mice from each control and four mice from each experimental group 
were analyzed, for a total of 14 preparations analyzed.  Total RNA was isolated from 
liver tissue using TRIzol reagent (Invitrogen) following the manufacturer’s instructions, 
and an RNeasy mini kit (Qiagen, Gaithersburg, MD) was used to further purify samples.  
The RNA was then labeled using the standard Affymetrix protocol for 3’-IVT arrays 
(Affymetrix, Santa Clara, CA).  Labeled cRNA was hybridized for 17 hours to the 
Affymetrix mouse 430 2.0 array.  The signal values and detection calls were derived 
using the MAS5 algorithm in Affymetrix GeneChip Operating Software.  Probe sets were 
eliminated from further analysis if an absent call was determined in greater than 50% of 
the samples in both the WT treated/untreated and LsPERK-KO treated/untreated.   
Filtered data was imported into Partek Genomics Suite (Partek, Inc.) where 
hierarchical clustering and principal components analysis were used to detect any outlier 
arrays, none were found.  P-values were determined for treatment condition (stress/no 
stress), genotype (WT/LsPERK-KO), and interaction terms by 2-Way ANOVA using the 
Partek software.  False discovery rates (FDR) were calculated according to Benjamini 
and Hochberg [98].  Probe sets that were not significantly changed during tunicamycin 
treatment were filtered out (p>0.05 or FDR>0.15), such that the resulting data set would 
further represent ER stress-dependent genes.  From this ER stress-dependent data, probe 
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sets that had an interaction p-value (condition*genotype) of p>0.05 were removed to 
enrich for the subset of PERK-dependent genes.   
The following gene ontology (GO) terms were used to identify genes in the 
PERK-dependent dataset that were linked with ER to Golgi transport:  Primary GO term, 
Biological process: 0006810 (transport).  Secondary GO terms, Gene Ontology Cellular 
Compartment:  0005783 (endoplasmic reticulum), 0005789 (endoplasmic reticulum 
membrane), 0000139 (Golgi membrane), 0005794 (Golgi apparatus).  Microarray data 
have been deposited in GEO (gene expression omnibus) (www.ncbi.nlm.nih.gov/geo/) 
under the accession number GSE29929.   
 Microarray technology was also used to distinguish differential transcription 
profiles between WT, CHOP
-/-
 and ATF5-kd cells.  Total RNA was extracted from WT 
and CHOP
-/-
 MEF cells using TRIzol reagent following the manufacturer’s instructions 
for adherent cells.  The crude RNA pellet was purified using an RNeasy kit (Qiagen, 
Gaithersburg, MD), and array hybridizations were carried as highlighted above and 
previously described [18].  Filtered data was imported into Partek Genomics Suite 
(Partek, Inc.) where hierarchical clustering and principal components analysis were used 
to detect any outlier arrays, none were found.  With respect to drug treatment significance 
was determined by t-test and genes were considered significantly changed if the p-value 
was less than 0.05 in the WT samples.  CHOP dependence was further defined from 
within this set of genes where a p-value of 0.05 between the WT and CHOP
-/- 
treated 
cells and fold change of WT/CHOP
-/-
 treated samples was greater than 1.0.  
Alternatively, cRNA derived from WT and ATF5-kd cells were hybridized to an 
Affymetrix Mouse 1.0 ST array.  Venn Diagrams were created with the help of an online 
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Venn diagram program (Venny).  CHOP dependent genes were also analyzed using 
Ingenuity Pathway analysis software package (Redwood, CA). 
 
2.9 Luciferase assays  
  Luciferase assays were carried out in 6-well plates using the Dual-Luciferase 
reporter assay system (Promega, Madison, WI) following the manufacturer’s instructions.  
The ATF6 expression plasmids were described by Prywes and colleagues [99].  For 
measurements of ATF6 transcriptional activity, plasmid p912 encoding five ATF6-
binding elements fused to the firefly luciferase reporter gene was co-transfected with a 
Renilla normalization plasmid into PERK
-/-
, ATF4
-/-
, A/A, and WT MEF cells.  
Measurements were determined as the RLU of the firefly luciferase normalized to Renilla 
luciferase.  Plasmid p1018 expressing ATF6 encoding residues1-500Δ431-475 [72] was 
co-transfected with p912 and the Renilla normalization plasmid into WT and ATF4
-/-
 
MEF cells, and the ATF6 transcriptional activity with the co-transfection of ATF6-1-
500Δ431-475 was determined.  The activity of the ATF6 gene promoter was measured by 
using a luciferase reporter assay.  A DNA segment encoding  -1500 to -1 bp relative to 
the transcriptional start site of the ATF6 gene was amplified using the primers F5’-
GGGACGCGTGCAAACGTGCAGCCTGGTCTGTATGTGGGTCCCC-3’ and R5’-
GGGCTCGAGCACCGCCCCGTGGCCTCCTGCCGCGCCCAGCCTTTCTAGG-3’ , 
with the Mlu1 and Xho1 restriction sites underlined.  The resulting PCR product was then 
digested and the DNA fragment was inserted using the Mlu1 and Xho1 restriction sites of 
the pGL3-basic vector (Promega), resulting in p1052.  The plasmid p1052 was co-
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transfected with the Renilla vector into, ATF4
-/-
, and WT MEF cells and the ATF6 
promoter activity was determined using the dual luciferase assay.   
 
Table 2-2 Plasmids used in this study. 
WB 
ID# 
Description Source 
912 5X ATF6 in pGL3 luciferase.  Contains 5 optimized ATF6 binding 
elements in tandem.   
Prywes 
984 pMDLg/pRRE Lenti (packaging)  from Addgene 3
rd
 generation 
plasmids, AmpR 
Cornetta 
985 pRSV-REV Lenti(packaging) from Addgene 3
rd
 generation 
plasmids, AmpR 
Cornetta 
986 pVSV-G Lenti (envelope) from Addgene 3
rd
 generation plasmids, 
AmpR 
Cornetta 
1015 pGL3 basic ATF5 promoter -3000bp AmpR This 
study 
1016 p3X Flag ATF6, AmpR Prywes 
1017 p3X Flag ATF6 (S1P-)  S1P cleavage site point mutation that 
generates Nhe1 restriction site, AmpR 
Prywes 
1018 p3X Flag ATF6 1-500 (Δ431-475) deletion of BIP binding site,  
Also deletes lumenal cysteines.  Also referred to as ATF6 
constitutively active mutant (ATF6-CAM), AmpR 
Prywes 
1019 p3X Flag ATF6 1-500 (Δ431-475) S1P- deletion of BIP binding site 
and lumenal cysteines.  Contains S1P point mutation generating 
unique Nhe1 site.  Golgi localized.  AmpR    
Prywes 
1027 pCMV-hATF5, AmpR Kirk 
1048 pGL3 basic luciferase reporter, AmpR Promega 
1052 pGL3 basic with -1500 to -1 of the ATF6 promoter by Mlu1/Xho1, 
AmpR 
This 
study 
1006 hCHOP, AmpR Kilberg 
1084 pLKO.1 scramble shRNA, AmpR Quilliam 
1142 shRNA hCHOP TRC identifier (last 2-digits) #28, AmpR Sigma-
Aldrich 
1143 shRNA hCHOP TRC identifier (last 2-digits) #63, AmpR Sigma-
Aldrich 
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1144 shRNA hCHOP TRC identifier last (2-digits) #64, AmpR Sigma-
Aldrich 
1145 shRNA hCHOP TRC identifier (last 2-digits) #65, AmpR Sigma-
Aldrich 
1146 shRNA hCHOP TRC identifier (last 2-digits) #67, AmpR Sigma-
Aldrich 
1147 shRNA mNOXA TRC identifier (last 2-digits) #06, AmpR Sigma-
Aldrich 
1148 shRNA mNOXA TRC identifier (last 2-digits) #07, AmpR Sigma-
Aldrich 
1149 shRNA mNOXA TRC identifier (last 2-digits) #08, AmpR Sigma-
Aldrich 
1150 shRNA mNOXA TRC identifier (last 2-digits) #16, AmpR Sigma-
Aldrich 
1151 shRNA mNOXA TRC identifier (last 2-digits) #57, AmpR Sigma-
Aldrich 
1160 shRNA mATF5 TRC identifier (last 2-digits) #49, AmpR Sigma-
Aldrich 
1161 shRNA mATF5 TRC identifier (last 2-digits) #46, AmpR Sigma-
Aldrich 
1162 shRNA mATF5 TRC identifier (last 2-digits) #57, AmpR Sigma-
Aldrich 
1163 shRNA mATF5 TRC identifier (last 2-digits) #70, AmpR Sigma-
Aldrich 
1164 shRNA mATF5 TRC identifier (last 2-digits) #82, AmpR Sigma-
Aldrich 
 
 
2.10 Statistics  
 Data were analyzed using two-way analysis of variance to
 
assess the main and 
interaction effects, with drug, and genotype as the independent variables (StatSoft, Tulsa, 
OK).  When a significant overall effect was detected, differences
 
among treatment groups 
were assessed with Duncan's Multiple
 
Range post-hoc test.  The level of significance was 
set at p<0.05 for all statistical tests.    
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2.11 Lentivirus shRNA knockdown   
 The protocol for Lentivirus particle preparation from Addgene 3
rd
 generation 
series of plasmids was used in conjunction with the validated mission shRNA TRC 
clones (Sigma) for generating lentivirus particles.  Briefly, three viral plasmids WB984, 
WB985, WB986, encoding packaging and envelope components, and one shRNA 
plasmid were co-transfected into HEK293T cells using Fugene 6 as a transfection 
reagent.  The following day media was removed and replaced with fresh growth media 
containing 25 mM HEPES.  Lentivirus containing media was collected and subject to 
centrifugation at 3,000 x g.   WT MEF cells or Hepa1-6 cells were transduced by 
replacing growth media with lentivirus containing media and the following day media 
was replaced with puromycin (10 μg/ml) containing media.  Cells were selected in the 
presence of puromycin until there were no surviving cells on the non-transduced plate.  
The shRNA expressing cells were then expanded and used for experiments. 
 
2.12 Chromatin immunoprecipitation  
 ChIP assay was performed essentially as described in a previous publication 
(Chen et al., 2004) with the following minor modifications.  About 5~10 X 10
6
 
immortalized mouse embryonic fibroblasts (MEF) were used per treatment.  Cells were 
cultured in Dulbecco’s modified Eagle’s medium (DMEM), pH 7.4 (Mediatech, 
Herndon, VA) supplemented with 1 X nonessential amino acids, 2 mM glutamine, 100 
mg/ml streptomycin sulfate, 100 U/ml penicillin G, 0.25 mg/ml amphotericin B, 10% 
(vol/vol) fetal bovine serum (FBS), and 1μM 2-Mercaptoethanol (#21985-023, 
Invitrogen, Carlsbad, CA) and maintained at 37°C in an atmosphere of 5% CO2 and 95% 
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air.  The cells were cultured to ~60-70% confluence so that the cells were still in a growth 
phase during the experiment.  At 12 to 16 h before initiation of treatment, cells were 
given fresh medium and serum to ensure that no nutrient deprivation took place before 
the start of experimental incubations.  To elicit the desired stress, cells were replenished 
with the medium containing 2 μM tunicamycin, 1 μM thapasgargin, or 1 μM MG132 for 
12 hours.  To fragment the chromatin, isolated nuclei were resuspended in 1 ml lysis 
buffer and sonicated for 2 times with the Fisher model 100 sonicator power level at 15 
watts.  Antibodies used in the ChIP assays include rabbit anti-ATF4 polyclonal (custom 
made by Cocalico Biotechnology Inc., Reamstown, PA), rabbit anti-GADD153 (CHOP) 
polyclonal antibody (Santa Cruz, CA, sc-575), and normal rabbit IgG (Santa Cruz, CA, 
sc-2027) was purchased from Santa Cruz Biotechnology, Inc.  DNA enrichment was 
analyzed with RT-qPCR with a DNA Engine Opticon 3 system (Bio-Rad) and detection 
with SYBR Green.  The reaction mixtures contained 2 μl purified DNA, 10 μl of SYBR 
Green master mixture and 5 pmol of forward and reverse primers in a total volume of 20 
μl.  Samples were incubated at 95°C for 15 min, followed by amplification at 95°C for 15 
s and 60°C for 60 s for 35 cycles.   All experiments were performed in triplicate.  The 
result was described as the ratio to a partial of total input DNA. 
 
2.13 Cell survival assays  
 The CellTiter 96 Non-Radioactive Cell Proliferation Assay (Promega G4001) is a 
colormetric assay the ability of living cells to convert a tetrazolium salt [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] in the dye solution into a colored 
formazan product.  This assay was used to determine cell viability in response to different 
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stress arrangements.  The assay was performed in a 96 well plate format and 
measurements of formazan product were carried out using a plate reader at an absorbance 
of 570 nm.  5,000 cells were plated per well in a 0.1 ml volume of DMEM supplemented 
with 10% FBS, 1 mM non-essential amino acids, 100 units/ml penicillin, and 100 µg/ml 
streptomycin.  After an overnight incubation, cells were cultured in the presence of 1 μM 
MG132 for 1, 3, 6, 12, or 18 hours, or no treatment.  Alternatively cells were incubated in 
the presence of 2-fold dilutions of 1 μM MG132 for 24 hours.  At the indicated time, the 
media containing the stress agent was removed by gentle aspiration with 0.5-10 μl pipet 
tips, and cells were then washed with warm media prior to incubation in DMEM in the 
absence of stress for a total of 24 hours from the beginning time of the stress treatment.  
For example, cells treated with MG132 for 1 hour, were washed and then cultured in the 
absence of this stress agent for 23 hours.  After the 24 hour period, 15 µl of the dye 
solution was added to a final volume of 115 µl, and then incubated with the cells for 4 
hours, followed by the addition of 100 µl solubilization solution, as described by the 
manufacturer’s protocol.  The formazan crystals were verified to be completely 
solubilized by inspection under the microscope and the absorbance of the solution was 
measured at 570 nm using a Spectra Max 340 96-well plate reader (Molecular Devices, 
Sunnyvale, CA). 
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CHAPTER 3.  RESULTS: THE ISR IS REQUIRED FOR ATF6 ACTIVATION 
3.1 Loss of PERK disrupts the UPR and renders the liver susceptible to ER stress   
To address the role of PERK in the UPR in liver, mice were bred with a liver-
specific knockout of PERK (LsPERK-KO).  LsPERK-KO mice were produced by 
deletion of floxed PERK
fl/fl 
using cre expression driven by the liver-specific albumin 
promoter, as described previously [49, 85].  Consistent with PERK depletion from the 
liver, there was significantly reduced eIF2~P following 6 hours of injection with 
tunicamycin (1 mg/kg), a potent ER stress agent that blocks N-glycosylation of proteins 
(Figure 3-1, A and B).  Disruption of eIF2~P in the LsPERK-KO livers was also 
observed following 24 and 36 hour treatments with tunicamycin.  In addition to 
translational expression of ATF4, induced eIF2~P enhances the transcription of ATF4 and 
its target gene CHOP, and the levels of both mRNAs were sharply reduced in the 
LsPERK-KO mice during ER stress (Figure 3-1C).  Expression of CREB-H, which has 
been previously linked to the UPR [100], was unchanged during the treatment with 
tunicamycin.  Accompanying this block in PERK activity and downstream gene 
expression, livers for the LsPERK-KO mice displayed substantial Oil red O staining, 
indicating the presence of fat deposits in response to 12 hours tunicamycin treatment 
(Figure 3-2A).  This staining was significantly reduced in the wild type (WT) mice.  
Triglycerides were also increased in livers of the LsPERK-KO mice treated with 
tunicamycin as compared to the WT (Figure 3-2B).  After 24 hours of the ER stress, 
increased TUNEL staining of hepatocytes in PERK-deficient mice, indicated enhanced 
apoptosis in the liver (Figure 3-2, C and D).  This was accompanied by elevated cleavage 
of caspase-3 in the LsPERK-KO livers (Figure 3-2E).  As expected, induction of CHOP 
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protein in response to ER stress was substantially diminished in the LsPERK-KO livers, 
consistent with the idea that activation of the ISR was blocked as illustrated by the 
lowered levels of eIF2α~P.  Interestingly, the mRNA and protein levels of the ER 
chaperone BiP were also substantially reduced with loss of PERK function, with only 
modest levels of BiP protein in the LsPERK-KO liver samples following 36 hours of 
tunicamycin treatment (Figures 3-1C and 2E).  These results suggest that PERK 
deficiency blocks induction of eIF2~P and the translational control arm of the UPR, 
which leads to disruption of liver homeostasis and increased apoptosis during ER stress.   
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Figure 3-1 Liver-specific knockout of PERK reduces eIF2~P and the ISR in response 
to tunicamycin treatment.  (A) WT and LsPERK-KO mice were injected 
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intraperitoneally with tunicamycin (TUN), and following 6, 24, or 36 hours of exposure 
to this ER stress agent, the levels of eIF2~P and total eIF2 in livers were measured by 
immunoblot analyses.  The “+” indicates treatment with tunicamycin, and the “-“ 
indicates injection with only excipient.  Results shown in each panel are representative of 
at least three independent experiments.  (B) Quantification of the levels of total and 
phosphorylated eIF2 in the WT and LsPERK-KO livers following 6 hours of treatment 
with tunicamycin (TUN) or with excipient (NT, no treatment).  (C) The levels of ATF4, 
CHOP, BiP and CREB-H mRNAs in the WT and LsPERK-KO livers exposed to 
tunicamycin for 6 hours, or to no treatment, were measured by quantitative PCR.  “*” 
indicates statistically significant differences (p<0.05) between the levels of tunicamycin 
treated (TUN) and no treatment (NT) samples; “#” indicates statistically significant 
differences (p<0.05) between WT and LsPERK-KO mice.  The error bar represents the 
S.E.M.   
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Figure 3-2 Loss of PERK enhances liver apoptosis in response to ER stress.  (A) WT 
and LsPERK-KO mice were injected intraperitoneally with tunicamycin or excipient 
(NT, no treatment).  Following 12 hours of exposure to the ER stress agent, a histological 
analysis of the livers was carried out using Oil Red O stain to visualize triglycerides, and 
liver sections were counter stained with hematoxillin.   (B) Quantification of triglyceride 
levels in WT and LsPERK-KO liver samples following treatment with tunicamycin 
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(TUN) or vehicle control (NT).  (C) WT and LsPERK-KO mice were treated with 
tunicamycin for 24 hours and a TUNEL analysis was carried out on liver histological 
sections, with the arrows indicating TUNEL-positive cells in a representative field.  (D) 
Quantification of the TUNEL-positive levels in WT and LsPERK-KO livers following 
the treatment with tunicamycin (TUN) or with no treatment (NT).  The error bar 
represents the S.E.M., and the “*” indicates statistically significant differences (p<0.05) 
between the tunicamycin treated and no treatment samples; “#” indicates statistically 
significant differences (p<0.05) between WT and LsPERK-KO mice.  (E) WT and 
LsPERK-KO mice were treated with tunicamycin (+) or vehicle only (-) for 6, 24, or 36 
hours and the levels of BiP, CHOP, and cleaved caspase-3 in liver lysates were measured 
by immunoblot analysis. 
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3.2 Loss of PERK in liver blocks activation of the UPR transcriptome 
An analysis of gene expression changes in the LsPERK-KO mice indicated that 
there was significantly diminished induction of BiP expression in response to ER stress.  
This suggested that in the liver, PERK normally enhances the expression of key ER 
chaperones, a function previously ascribed to ATF6 and IRE1/XBP1 [3, 4, 36, 101].  To 
investigate changes in UPR genes which require PERK, total RNA was isolated from WT 
and LsPERK-KO livers and analyzed by Affymetrix microarrays.  In WT livers, 9,645 
probe sets were significantly changed by tunicamycin treatment, with nearly 50% of 
these being induced by 2.0-fold or greater (Table 3-1; p ≤ 0.05, fdr ≤ 0.15).  A 
comparison between the induction ratios (stress/control) for the ER stress-induced genes 
in the WT versus the PERK-deficient livers indicated that 63% (4599/7324) displayed a 
significantly lower induction ratio in the LsPERK-KO mice.  Furthermore, among those 
genes enhanced ≥2-fold by tunicamycin treatment, 74% (3523/4737) showed a 
requirement for PERK for full induction in response to ER stress (Table 1).  These 
finding are illustrated in Figure 3-3A, which features a comparative analysis between the 
stress-induced transcriptome changes in WT (x-axis) versus LsPERK-KO (y-axis).  The 
PERK requirement for changes in the UPR transcriptome is supported by the large 
number of probe sets which were increased in the WT livers upon ER stress, but lie 
below the diagonal where y=x.   
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Table 3-1 PERK facilitates expression of a large number of UPR target genes. 
  Fold Change (Treated/Untreated)
a
 
Dependence Total > 1.0 ≥ 2.0 < 1.0 ≤ 0.5 
WT 9645
b
 7324 4737 2321 797 
PERK-dep 4948
c
 4599 3523 349 190 
a 
Expression profile summary of gene transcripts, as defined by probe set, that were 
significantly changed after treatment with tunicamycin (1mg/kg).  The number of induced 
genes are shown for both the >1.0 fold and ≥2.0 fold thresholds.  The repressed genes are 
also shown for the < 1.0 and < 0.5 fold thresholds  
b 
The total number of transcripts significantly changed (p≤0.05) by ER stress.   
c 
The number of PERK-dependent transcripts that were significantly changed by ER 
stress.   
 
These results indicate that PERK is a major participant in the transcriptional phase 
of the UPR, with a majority of activated genes requiring PERK function for full 
induction.  As expected, these PERK-dependent genes included canonical ISR target 
genes such as ATF4, CHOP, GADD34, ATF3, and TRIB3 (Figure 3-3B).  However, many 
UPR target genes also required PERK for full induction in response to tunicamycin 
treatment, including those involved in protein folding and ERAD (Figure 3-3C).  To 
address the apparent overlap between PERK and ATF6 transcriptional target genes, we 
compared a previously reported microarray characterization of livers from ATF6 
knockout mice treated with tunicamycin with our LsPERK-KO dataset [17].  A total of 
2,487 genes were significantly induced by ER stress in both datasets, with 39% 
(969/2,487) of these requiring ATF6 for full induction (Figure 3-3D).  Importantly, 
among these ATF6-target genes, 69% (671/969) were also dependent on PERK for full 
induction.  We conclude that PERK facilitates not only the expression of the ISR genes, 
but also a majority of the UPR genes, including those targeted by ATF6.   
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Figure 3-3  PERK is required for full induction of a majority of the UPR-targeted 
genes.  (A) The scatter plot is the log ratio of stressed vs no stress for WT (x-axis) and 
LsPERK-KO (y-axis).  This comparative analysis of gene transcripts induced or 
repressed by ER stress in the livers of WT mice and LsPERK-KO mice displays all 
significant probe sets (p<0.05) following treatment with 2 µM tunicamycin for 6 hours.  
Microarray measurements of gene transcripts targeted by the ISR (B) and the UPR (C) 
shown as mean fluorescent intensity (MFI) for each transcript is shown as a histogram, 
along with the S.D.   Each of these representative genes showed a significant induction in 
response to ER stress that was dependent on PERK (p≤0.05, fdr≤0.15).  (D) Comparative 
analysis of genes induced by tunicamycin in mice livers.  The LsPERK-KO microarray 
analysis described here was compared with microarray measurements derived from ATF6 
liver-specific knockout mice as reported by Rutkowski et al [17].  Genes significantly 
induced by ≥ 2-fold were plotted by the Venn diagrams.  Shown here are genes induced 
by tunicamycin in liver that were present in both microarray datasets (Blue), with  ATF6-
dependent genes (Green),  PERK-dependent genes (Red), and PERK and ATF6-
dependent genes (Yellow). 
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Turnover of a large number of gene transcripts is enhanced in response to ER 
stress [6, 7].  There were 2,321 gene transcripts that were significantly reduced in WT 
livers upon tunicamycin treatment, with 797 being lowered by at least 2-fold (Table 3-1).  
PERK contributed to 24% of those genes repressed by 2-fold or greater (190/797).  This 
is illustrated in Figure 3-3A, with the repressed transcripts in WT livers (x-axis) lying 
above the y=x diagonal.  Turnover of a large number of mRNAs is known to be enhanced 
in response to ER stress, and the endoribonuclease activity of IRE1 is thought to facilitate 
the decay of many of these mRNAs [6, 7].  These results suggest that PERK is also a 
significant contributor to the repression of the transcriptome in response to ER stress.   
 
3.3 PERK facilitates activation of ATF6 in response to ER stress   
Our microarray analysis suggested that both ATF6 and XBP1 mRNA expression 
were substantially diminished in LsPERK-KO mice subjected to tunicamycin treatment 
compared to WT, results that were confirmed by qPCR measurements (Figures 3-3C and 
3-4A).  These findings support the idea that PERK can facilitate activation of the UPR 
transcriptome by contributing to the activation of ATF6 and XBP1 during ER stress.  
While loss of PERK lowered the total levels of XBP1 mRNA, and as a consequence the 
amount of spliced XBP1 mRNA in response to ER stress, the ratio of spliced/total XBP1 
transcript was unchanged between the LsPERK-KO and WT mice (Figure 3-4A).  This 
suggests that within this timeframe of ER stress, IRE1 endoribonuclease activity for 
XBP1 mRNA cleavage is not significantly altered by loss of PERK function.   
Given the larger than expected role for PERK in UPR-directed gene expression, 
we next addressed whether loss of this eIF2 kinase could adversely affect the activation 
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of ATF6 in response to ER stress.  Consistent with our previous results, PERK deficiency 
significantly reduced eIF2~P following 6 hours of tunicamycin treatment (Figure 3-4B).  
Immunoblot analyses comparing the levels of the full-length (ATF6-FL/G) and processed 
ATF6(N) protein in WT and LsPERK-KO indicated that activation of ATF6 was 
dramatically reduced with loss of PERK function (Figure 3-4B).  Following treatment of 
the WT mice with tunicamycin, there was accumulation of unglycosylated full-length 
ATF6 (ATF6-FL/UG), along with the proteolytically cleaved and activated ATF6(N).  
Cleavage of ATF6 was dependent on PERK following 6 hours of ER stress.  We note that 
the size of the ATF6(N) protein is consistent with that determined using an ATF6 
expression plasmid encoding residues 1-373 (HA-ATF6-1-373) transfected into cultured 
mouse embryonic fibroblasts (MEF) (Figure 3-5).  Furthermore, ATF6 was reported to be 
glycosylated at multiple sites [102], and as described below, the ATF6-FL/UG was 
detected in MEF cells treated with tunicamycin, but not detected in response to 
thapsigargin, another well-characterized ER stress agent that does not directly inhibit 
protein glycosylation [4, 102].  These results indicate that PERK facilitates activation of 
ATF6 in response to ER stress, providing an important rationale for why loss of PERK 
has such a broad impact on the UPR transcriptome.   
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Figure 3-4 PERK facilitates activation of ATF6 in the liver following tunicamycin 
treatment.  (A) WT and LsPERK-KO mice were treated with tunicamycin (TUN) or 
excipient (NT, no treatment) for 6 hours and the levels of ATF6, XBP1, and spliced XBP1 
mRNA were measured by quantitative PCR.  The ratio of spliced XBP1 mRNA versus 
total XBP1 transcripts was also determined (XBP1spl/XBP1tot).  The error bar represents 
the S.D., and the “*” indicates statistically significant differences (p<0.05) between 
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tunicamycin treatment and non ER stress.  The “#” symbol indicates significant 
differences (p<0.05) between the WT and LsPERK-KO livers.  (B)  Activation of ATF6 
was measured by immunoblot analysis using whole cell lysates prepared from WT and 
LsPERK-KO livers following tunicamycin treatment for 6 hours or no treatment (NT) 
control.  The arrows indicate full-length glycosylated ATF6 (ATF6-FL/G), full-length 
unglycosylated (ATF6-FL/UG), and the cleaved ATF6(N) proteins.  Two or three 
different liver samples are shown for each treatment group in the immunoblot panels.  
The position of the molecular weight standards (KDal) in the SDS-PAGE are shown to 
the right of the panel, and “*” designations indicate proteins that cross-react with the 
antibody prepared against recombinant ATF6 protein.  Additionally, the levels of eIF2~P 
and total eIF2 were measured by immunoblot analyses using antibodies specific to each 
version of this translation initiation factor.   
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Figure 3-5 ATF6 antibody detects endogenous and over-expressed ATF6 in MEF 
cells.  WT MEF cells were transfected with an HA-tagged ATF6 expression plasmid 
encoding residues 1-373 (+), or no expression plasmid (-).  Cells were then treated (+) for 
3 hours with 2 μM tunicamycin, or left untreated (-).  Cell lysates were prepared and 
analyzed by immunoblot using antibody that recognizes ATF6, the HA tag, or actin. 
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We next addressed whether PERK also facilitates activation of ATF6 in cultured 
MEF cells exposed to ER stress agents.  WT MEF cells were treated with tunicamycin, 
thapsigargin, or DTT for up to 6 hours and ATF6 levels were measured by immunoblot 
analyses.  Consistent with our liver analysis, we found that tunicamycin triggered 
accumulation of the cleaved ATF6(N), initiating at 1 hour of treatment and continuing 
through the 6 hour regimen (Figure 3-7A).  Accumulation of ATF6(N) coincided with the 
induction of ATF4 expression, which was readily detected following 2 hours of the ER 
stress.  During the time course of tunicamycin exposure, there was also a gradual 
decrease of ATF6-FL/G coincident with increasing ATF6-FL/UG.  The ATF6-FL/UG is 
suggested to represent ATF6 that is newly synthesized during ER stress, as the addition 
of cycloheximide, a potent inhibitor of protein synthesis, along with tunicamycin resulted 
in minimal detection of ATF6-FL/UG (Figure 3-7B).  Thapsigargin treatment also 
triggered accumulation of ATF6(N); however in this case there was no detectable ATF6-
FL/UG (Figure 3-7A).  As a consequence we did not detect measureable reduction of 
ATF6-FL/G during the time course of thapsigarin treatment, as the synthesis of ATF6 is 
sufficient to replace that being processed into the activated ATF6(N).  Treatment with 
DTT resulted in rapid processing of ATF6 that exceeded the rate of protein synthesis 
resulting in no detectable ATF6-FL/G at the early time points (1 and 2 hours).  However, 
this ATF6 synthesis was partially recovered at the later time points (3-6 hours).   
Similar ER stress treatments of PERK
-/-
 MEF cells revealed a substantial 
reduction of ATF6(N) after 6 hours of tunicamycin or thapsigargin exposure, although 
there was some cleaved ATF6(N) product at the earlier time points (Figure 3-7, C and D).  
A/A MEF cells expressing eIF2 containing alanine substituted for the phosphorylation 
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residue, serine-51, also showed reduced ATF6(N) levels following tunicamycin or 
thapsigargin treatments (Figure 3-8, A and B).  This was most apparent after 6 hours of 
ER stress, with minimal detectable ATF6(N) in the mutant cells devoid of eIF2~P.  It is 
noted that some ATF6(N) was detected in the A/A cells at earlier exposure times to 
tunicamycin or thapsigargin.  As expected, induced eIF2~P levels were significantly 
reduced in the PERK
-/-
 cells in response to these ER stress conditions, and eIF2 α ~P was 
absent in the A/A cells (Figures 3-6C, 3-6D, 3-7A, and 3-7B).  These results indicate that 
PERK mediated eIF2~P is required for full activation of ATF6 in response to different 
ER stress conditions both in vivo and in cultured cells. 
To determine if reduced ATF6(N) protein in PERK
-/-
 and A/A MEF cells also 
resulted in lowered ATF6 transcriptional activity, we used an ATF6 sensitive luciferase 
reporter expressed from a promoter containing five optimized UPREs [99].  This reporter 
system is potently induced by ATF6, although it is noted that that XBP1 has also been 
shown to contribute to activation of the UPRE based promoters [36].  WT cells 
transfected with this reporter plasmid showed about a 12-fold increase in ATF6 
transcriptional activity after 6 hours of tunicamycin treatment (Figure 3-8C).  By 
comparison, ATF6 activity was lowered by over 50% in the PERK
-/-
 and A/A mutant cells 
during ER stress.  Collectively, these results indicate that disruption of PERK 
phosphorylation of eIF2 reduces both ATF6 proteolysis and transcriptional activity.   
 
3.4 ATF4 is required for activation of ATF6 
Because PERK facilitates eIF2~P leading to the preferential translation of ATF4, 
we next sought to determine if ATF4 was required for ATF6 activation in response to ER 
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stress.  In response to thapsigargin, there was a significant reduction of ATF6(N) in the 
ATF4
-/- 
MEF cells, and ATF6-FL/G was substantially reduced by 6 hours of treatment 
(Figure 3-7D).  We also addressed the role of ATF4 in the activation of ATF6 in response 
to up to 8 hours of tunicamycin treatment (Figure 3-8E).  In the absence of stress (0 
hours) there was a greater than 40% reduction of ATF6-FL/G in ATF4
-/-
 MEF cells when 
compared to the WT control.  Thus in both thapsigargin and tunicamycin treatments, 
there was minimal accumulation of ATF6(N) in ATF4
-/-
 MEF cells.  Following the time 
course, we also found that in WT MEF cells there was a greater rate of reduction of 
ATF6-FL/G, and as a consequence more accumulation of active ATF6(N), when 
compared to ATF4
-/-
 MEF cells (Figure 3-8E).  Furthermore, the accumulation of the 
newly synthesized ATF6-FL/UG required to replenish ATF6 protein levels was delayed 
in  ATF4
-/-
 cells during the exposure to tunicamycin (Figure 3-8E).   
The next question addressed was whether preconditioning of the ISR and 
induction of ATF4 could restore ATF6 activation in PERK
-/-
 MEF cells treated with ER 
stress (Figure 3-8F).  For this experiment, induction of ATF4 was achieved by treating 
PERK
-/-
 MEF cells with a derivative of salubrinal (Sal003), which is an inhibitor of the 
PP1c regulatory subunits, CReP and GADD34, that are required for eIF2~P 
dephosphorylation [57].  The Sal003 treatment for 1 hour prior to adding the ER stress 
agent tunicamycin resulted in ATF4 protein levels that were sustained in PERK
-/-
 cells 
during the ER stress time course.  Induction of ATF4 expression in PERK
-/-
 cells with 
this treatment regimen also rescued the processing of ATF6, supporting the idea that 
eIF2~P and ATF4 are required for ATF6 activation (Figure 3-8F).  These results indicate 
that the ATF4 transcription factor is also central to activation of ATF6 in response to 
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different ER stress conditions.  Further supporting this finding, loss of ATF4 resulted in 
significantly reduced ATF6 transcriptional activity upon ER stress, as measured by the 
luciferase reporter plasmid containing the optimized ATF6-binding sites (Figure 3-8C). 
We considered three models to explain the underlying mechanisms by which the 
PERK/eIF2~P/ATF4 pathway facilitates ATF6 activation, and it is noted that these ideas 
are not mutually exclusive.  The first is the Stability model, in which the PERK pathway 
facilitates stabilization of ATF6(N), thus contributing to enhanced levels of this activated 
form of ATF6.  The second is the Synthesis model, which posits that ATF4 enhances 
ATF6 expression, therefore increasing the amount of full-length ATF6 entering into the 
secretory pathway for processing in the Golgi.  Lastly, the Trafficking model, focuses on 
ER to Golgi transport and suggests that the PERK/eIF2~P/ATF4 pathway is important for 
key features of ATF6 anterograde transport to the Golgi for cleavage by S1P and S2P.  
These models of, Stability, Synthesis, and Trafficking, are depicted in Figure 3-6 and will 
be experimentally addressed below.   
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Figure 3-6 Model for the ISR requirement in the activation of ATF6.  The 
PERK/eIF2~P/ATF4 pathway is proposed to be required for the synthesis, ER-Golgi 
trafficking, and/or stability of ATF6.  These three possible models are depicted with red 
“?” marks and dashed arrows.   These models will be tested empirically in this thesis.   
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Figure 3-7 PERK is required for full activation of ATF6 in MEF cells in response to 
different ER stress conditions.  (A) WT MEF cells were treated with 2 µM tunicamycin 
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(TUN), 1 μM thapsigargin (TG) or for between 1 and 6 hours, as indicated, or with no 
stress treatment (0).  Equal amounts of the protein lysates prepared from the cultured 
cells were separated by SDS-PAGE, and the levels of ATF6, ATF4, and actin were 
measured by immunoblot analysis.  The arrows indicate the glycosylated (ATF6-FL/G) 
and unglycosylated (ATF6-FL/UG) versions of full-length ATF6, and the cleaved 
ATF6(N) proteins.  (B) WT MEF cells were treated with 2 μM tunicamycin (TUN), 
tunicamycin and 50 μg/ml cycloheximide (TUN/CHX), or cycloheximide alone (CHX) 
for up to 6 hours as indicated.  The levels of ATF6-FL/G, ATF6-FL/UG, and actin were 
measured by immunoblot analysis.  (C and D) WT and PERK
-/-
 MEF cells were treated 
with tunicamycin (TUN) or thapsigargin (TG) for up to 6 hours, and the levels of ATF6, 
eIF2~P, and total eIF2 were measured by immunoblot.  The position of the molecular 
weight standards (kDa) are shown to the right of the ATF6 panel. 
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Figure 3-8 Phosphorylation of eIF2 and ATF4 facilitate activation of ATF6 in 
response to ER stress.  (A and B) WT and A/A MEF cells were treated with 2 μM 
tunicamycin (TUN) or 1 μM thapsigargin (TG) for between 1 and 6 hours, as indicated, 
or with no stress treatment (0).  Equal amounts of the protein lysates prepared from the 
cultured cells were analyzed by immunoblot analysis using antibodies specific to ATF6, 
eIF2~P, and total eIF2.  The arrows indicate full-length ATF6-FL/G and ATF6-FL/UG, 
and the cleaved ATF6(N) proteins.  Molecular weight standards in kDal are shown to the 
right of the panels.  (C) To measure ATF6 transcriptional activity, a firefly luciferase 
reporter with a promoter containing 5X ATF6-binding elements was co-transfected with 
a Renilla normalization plasmid into PERK
-/-
, ATF4
-/-
, A/A, and WT MEF cells.  The 
transfected cells were treated with thapsigargin for 6 hours or no stress agent and the 
ATF6 transcriptional activity was measured by using a dual luciferase reporter assay.  
The values represent the fold-change in relative light units (RLU) after treatment with ER 
stress for each transfected cell type.  The error bar represents the S.D.  and the “*” 
indicates a significant (p<0.05) difference when compared to WT cells.  (D) WT and 
ATF4
-/-
 MEF cells from two independently derived cell lines were treated with 
thapsigargin (TG) and the levels of ATF6, ATF4, and actin were measured by 
immunoblot.  (E) WT and ATF4
-/-
 MEF cells were treated with tunicamycin (TUN) for up 
to 8 hours as indicated levels of ATF6, ATF4 and actin were measured by immunoblot.  
Panels are representative of three independent experiments.  (F) Quantitative analysis of 
ATF6-FL/G and ATF6-FL/UG in WT and ATF4
-/-
 MEF cells.  This Figure shows three 
experimental replicates of WT and ATF4 treated with tunicamycin for up to 10 hours as 
indicated, levels of the ATF6-FL/G and ATF6-FL/UG proteins from the immunoblot 
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analysis were measured by densitometry.  The graphs below indicate the fraction of 
ATF6 protein relative to the ATF6-FL/G in the untreated (0 hours) controls.  
Measurements from WT cells are shown as a solid black line (diamonds) and 
measurements for ATF4
-/-
 cells are shown as a dotted line (open squares).  (G) WT and 
PERK
-/-
 MEF cells were treated with tunicamycin for up 6 hours, or no ER stress (0).  
Where indicated, Sal003 was added to the PERK
-/-
 cells 1 hour prior to addition of 
tunicamycin.  Sal003 was either ‘removed’ after 1 hour or ‘left in’ during the ER stress 
time course.  Levels of ATF6, ATF4, and actin were measured by immunoblot.   
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3.5 Stability of ATF6 is independent of PERK and ATF4   
The first model to be addressed concerns the role of the PERK pathway in the 
stabilization of ATF6.  ATF6(N) is suggested to have a short half-life (t1/2~ 1 hour) by a 
mechanism involving degradation through the ubiquitin/proteasome pathway [103].  
Basic zipper (bZIP) transcription factors, such as ATF6 and ATF4, are often labile and 
have been shown to require partner proteins for stability [24, 104, 105].  We sought to 
determine if induction of the PERK/eIF2~P/ATF4 pathway stabilized ATF6(N).  First, 
WT and ATF4
-/-
 MEF cells were treated with tunicamycin in the presence or absence of 
MG132, a potent proteasome inhibitor [106].  Enhanced ATF6(N) levels were detected in 
both WT and ATF4
-/-
 cells, although the total accumulation of ATF6(N) was significantly 
greater in WT cells (Figure 3-8A).  This finding is consistent with the earlier report 
suggesting that ATF6 is subject to degradation by the proteasome pathway.  It is also 
noted in these MEF cells that 6 hours of treatment with MG132 alone does not induce ER 
stress, as judged by accumulation of ATF6(N) and splicing of XBP1 mRNA [107].  As a 
control, other ISR inducible transcription factors, ATF4 and CHOP, which are also short-
lived [104, 105], showed similar increases when MG132 was combined with the 
tunicamycin treatment in WT cells.  In the ATF4
-/-
 cells, there was no detectable ATF4 
transcription factor and its target CHOP showed some enhanced accumulation in the 
combined tunicamycin and MG132 treatments, although significantly less than that 
measured in WT cells.  Consistent with our earlier experiments, there were also minimal 
detectable ATF6-FL/UG levels in the ATF4
-/-
 cells in response to tunicamycin treatment 
in the presence or absence of MG132 (Figure 3-8A).  This finding suggests that ATF4 
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contributes to the synthesis of ATF6 in response to ER stress, an idea that will be 
explored more fully below.   
We next directly measured the half-life of ATF6(N) in WT and ATF4
-/-
 cells.  
Because the steady-state levels of ATF6(N) are a consequence of both the processing of 
full-length ATF6 and the turnover of ATF6(N), a HA-tagged version of ATF6(N) 
containing amino acid residues 1-373 (HA-ATF6-1-373) was expressed in both WT and 
ATF4
-/-
 MEF cells.  The synthesis of the HA-ATF6-1-373 would therefore occur 
independent of intramembrane proteolysis and the HA tag would allow for the expressed 
ATF6 protein to be distinguishable from endogenous ATF6.  MEF cells expressing HA-
ATF6-1-373 were either untreated or exposed to tunicamycin for 3 hours.  Induction of 
CHOP was used as a control, as it is robustly induced after 3 hours of ER stress by a 
mechanism requiring ATF4.  These cells were then subjected to treatment with 
cycloheximide and the rate of turnover of the tagged ATF6(N) protein was monitored.  
There was no appreciable difference in the rate of decay of the HA-ATF6-1-373 protein 
in the WT MEF cells in the presence or absence of ER stress (Figure 3-8B).  In both 
cases, the activated version of ATF6 displayed a half-life of about 3 hours.  Furthermore, 
loss of ATF4 did not alter the rate of turnover of the HA-ATF6-1-373 protein (Figure 3-
8C).  Based on these findings, we conclude that the PERK/ATF4 pathway is not a 
significant contributor to the stability of ATF6-FL and the activated ATF6(N).    
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Figure 3-9 ATF6(N) protein has a short-half life that is independent of ATF4.  (A) 
WT and ATF4
-/-
 MEF cells were treated with tunicamycin (TUN), or co-treated with 
tunicamycin and MG132 (TUN/MG132) for up to 6 hours, as indicated.  The levels of 
ATF6-FL/G, ATF6-FL/UG, ATF6(N), ATF4, CHOP, and actin were measured by 
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immunoblot analysis.  Each panel was derived from a single immunoblot and is 
representative of three independent experiments.  (B and C) WT and ATF4
-/-
 cells were 
subject to the same treatment regimen.  The half-life of ATF6(N) was measured in these 
cells by introducing a plasmid expressing an HA-tagged version of ATF6 encoding 
residues 1-373 (HA-ATF6-1-373).  Cells were pre-treated with 2 μM tunicamycin for 3 
hours, or exposed to no ER stress, followed by the addition of 50 μg/ml cycloheximide.  
Cells were then cultured for up to 8 hours as indicated, and the HA-ATF6-1-373 (HA), 
CHOP, or actin proteins were measured by immunoblot analysis.  (D) WT and ATF4-/- 
cells were treated with 50 μg/ml cycloheximide for the indicated times and the levels of 
ATF6-FL/G was measured by immunoblot analysis.   
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3.6 The PERK/eIF2~P/ATF4 pathway facilitates increased ATF6 expression during 
the UPR 
 An important contributing factor to the activation of ATF6 during ER stress is 
induced synthesis of the full-length ATF6 protein.  This continual renewal of full length 
ATF6 is required to replenish the full-length ATF6 that is irreversibly cleaved to generate 
ATF6(N).  The Synthesis model suggests that disruption of the PERK/eIF2~P/ATF4 
pathway lowers the levels of ATF6(N) by blocking the induced synthesis of full-length 
ATF6.  Synthesis of the full-length protein is required for continued availability of this 
substrate for intramembrane proteolysis during ER stress.  We initially addressed this by 
determining the requirement for global transcription in the accumulation of ATF6(N).  
Increasing amounts of ATF6(N) were detected between 1 and 6 hours of tunicamycin 
treatment (Figure 3-9A).  This was accompanied by a depletion of ATF6-FL/G that was 
nearly absent by 6 hours of exposure to tunicamycin and by accumulation of ATF6-
FL/UG, which represented the ATF6 protein newly synthesized during the ER stress 
condition.  By comparison, a 30 minute pretreatment with actinomycin D, a potent 
inhibitor of RNA polymerase II, led to a more rapid depletion of ATF6-FL/G, and 
reduced levels of ATF6-FL/UG and ATF6(N) during the time course of tunicamycin 
treatment.  These results suggest that transcription is an important contributor to 
accumulation of ATF6(N) during ER stress.  This result is consistent with the idea that 
synthesis of ATF6 replenishes the processing pathway of ATF6, insuring a continued 
source of full length ATF6 for cleavage into the labile ATF6(N) transcription factor.   
Induced ATF6 synthesis is suggested to involve increased transcription of ATF6, 
as there was a 2 to 3-fold increase in ATF6 mRNA during tunicamycin treatment (Figure 
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3-9B).  As described earlier in the LsPERK-KO mice (Figure 3-4A), loss of PERK or 
ATF4 in the MEF cells blocked the increase in ATF6 mRNA in response to ER stress 
(Figure 3-9B).  Also consistent with the earlier LsPERK-KO experiments, there was 
significantly lowered induction of total and spliced XBP1 mRNA levels during 
tunicamycin treatment in PERK
-/-
 or ATF4
-/-
 cells (Figure 3-9).  To further support the 
idea that ATF4 facilitates the transcription of ATF6, we measured the activity of the 
ATF6 promoter fused to a firefly luciferase reporter that was transfected into WT or 
ATF4
-/-
 MEFs.  While there was about 1.5-fold increase in the ATF6 promoter activity in 
WT cells upon treatment with tunicamycin, loss of ATF4 blocked induction of the ATF6 
promoter (Figure 3-9C).  These results indicate that ATF4 enhances the transcription of 
the ATF6 gene. 
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Figure 3-10 PERK and ATF4 facilitate increased expression of the ATF6 gene in 
response to ER stress.  (A) WT MEF cells were treated with tunicamycin (TUN), 10 μM 
actinomycin D and tunicamycin (AD/TUN), or actinomycin D (AD) alone for up to 6 
hours, as indicated.  The levels of ATF6-FL/G, ATF6-FL/UG, and actin were measured 
by immunoblot analysis.  (B)  PERK
-/-
 and ATF4
-/-
 MEF cells, and their WT counterparts, 
were treated with tunicamycin for up to 6 hours, and the levels of ATF6 mRNA were 
measured by qPCR.  (C) A 1.5-kb segment (-1500 to -1) of the ATF6 promoter was fused 
to a firefly luciferase reporter and assayed for expression in MEF cells treated with 
tunicamycin for 6 hours, or no stress agent.  The fold-change in ATF6 promoter activity 
in response to ER stress was determined by the dual luciferase assay.   In panels B and C, 
the error bar represents the S.D., and the “*” indicates significance between untreated and 
treated samples;  the “#” indicates significance between cell types, with a p<0.05.  (E) 
WT and PERK
-/-
 MEF cells were treated with 2 μM tunicamycin (TUN), as indicated, and 
mRNA levels for spliced XBP1, total XBP1, and ATF4 were measured by qPCR.  The “*” 
symbol indicates a significant difference (p<0.05) between tunicamycin treated and non-
stressed samples, and the “#” symbol represents a significant difference between cell 
types.  (F) WT and ATF4
-/- 
MEF cells were treated with 2 μM tunicamycin (TUN), as 
indicated.  The mRNA levels for spliced XBP1, total XBP1, and ATF4 were determined 
by qPCR.  The “*” symbol highlights a significant difference (p<0.05) between 
tunicamycin treated and non-stressed samples, and the “#” symbol indicates a significant 
difference between WT and ATF4
-/- 
cells. 
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3.7 ATF4 facilitates trafficking of ATF6 from the ER to the Golgi 
A final model to explain the role of the PERK/eIF2~P/ATF4 pathway in the 
activation of ATF6 suggests that this pathway facilitates the cellular trafficking of ATF6 
during ER stress.  In support of this model, our earlier observations showed that the rate 
of decrease of ATF6-FL/G in response to ER stress was slower in the ATF4
-/-
 cells versus 
WT, which was accompanied by reduced levels of cleaved ATF6(N) (Figure 3-8E).  We 
employed two experimental approaches to address whether ATF4 facilitates ATF6 
trafficking.  First, we used brefeldin A, a chemical inhibitor of anterograde ER-Golgi 
vesicle trafficking that causes S1P and S2P relocalization from the Golgi compartments 
to the ER [33, 34, 108].  We reasoned that brefeldin A would trigger a redistribution of 
Golgi proteins, including the S1P and S2P proteases, to the ER causing cleavage of ATF6 
that was independent of trafficking.  Consistent with an earlier study [34], there was an 
accumulation of ATF6(N) in WT cells within 2 hours of brefeldin A exposure (Figure 3-
10A).  This was accompanied by accumulation of ATF4 beginning at 3 hours of 
treatment, suggesting that at later time points brefeldin A can stress the ER organelle.  
Importantly, this pattern of ATF6 activation by brefeldin A was not changed in the 
absence of ATF4, with similar levels of ATF6(N) accumulated at each of the time points 
(Figure 3-10A).  This finding demonstrates that the S1P and S2P proteases are active in 
the ATF4
-/-
 cells, and supports the idea the ATF4 is required to facilitate passage of ATF6 
from the ER to Golgi.   
Trafficking and activation of ATF6 is suggested to involve multiple steps, 
including the reduction of the disulfide bonds which facilitates deoligomerization of 
ATF6 into ATF6 monomers, the release of inhibitor BiP [35, 72], and the loading of 
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ATF6 into COPII vesicles for transport from the ER to Golgi [31].  Prywes and 
colleagues showed that deletion of the BiP binding domain and the cysteine residues 
from the luminal portion of ATF6 (1-500 Δ431-475) leads to a constitutively active 
transcription factor that is transported to the Golgi for cleavage independent of ER stress 
[72].  Consistent with this idea, we found that expression of ATF6-1-500 Δ431-475 in 
non-stressed WT MEF cells led to a significant increase in ATF6 activity as measured by 
luciferase reporter expressed from a promoter with optimized ATF6-binding elements 
(Figure 3-10B).  However, the ATF6 activity was blocked when the ATF6-1-500 Δ431-
475 was expressed in the ATF4
-/-
 cells.  In contrast, when WT and ATF4
-/- 
MEF cells 
were transfected with the ATF6(N) (residues 1-373) construct that is not dependent on 
Golgi processing, transcriptional activity was similarly induced in both WT and ATF4
-/- 
cells.  These results suggest that even when ATF6 is readily released from the ER, loss of 
ATF4 function interferes with the passage of ATF6 to the Golgi for processing by S1P to 
S2P proteases.   
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Figure 3-11 ATF4 is dispensable for activation of ATF6 in response to brefeldin A 
treatment.  (A) WT and ATF4
-/-
 MEF cells were treated with 5 μg/ml Brefeldin A (BFA) 
for up to 5 hours, and the levels of ATF6-FL/G, ATF6(N), ATF4, and actin were 
measured by immunoblot analysis.  (B)  Plasmids encoding ATF6-1-500Δ431-475 or 
ATF6-1-373 (indicated by “+”), along with a firefly luciferase reporter containing a 
76 
 
promoter with 5X ATF6-binding elements, were introduced into WT and ATF4
-/-
 MEF 
cells.  Luciferase values normalized to a Renilla internal control are shown and a “*” 
symbol represents significance (p<0.05) with respect to untransfected control and the “#” 
symbol shows significance between cell types, the error bars represent the S.D.  (C) 
Graphical representation of the expression of genes involved in ER-Golgi trafficking that 
are Perk dependent.  The mean fluorescent intensity (MFI) for each transcript is shown as 
a histogram, along with the S.D.  (D) WT and ATF4
-/-
 MEF cells were treated with 
tunicamycin for up to 6 hours, as indicated.  The mRNA levels of NAPA, NAPB, and 
STX5A were measured by qPCR.  The “*” indicates a significant difference was detected 
between the cell types. 
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3.8 ATF4 facilitates gene expression important for trafficking to the Golgi  
Given that ATF4 facilitates trafficking of ATF6 from the ER to Golgi, we 
reasoned that ATF4 may induce the expression of genes involved in ER to Golgi 
transport.  In our microarray analysis, a number of the genes that showed a PERK-
dependent induction in response to tunicamycin are known to participate in this 
trafficking process (Figure 3-11C).  These genes include COPII vesicle coat proteins, 
GTPase activating proteins (GAPs), and genes associated with vesicle formation and 
fusion such as STX5a [109, 110] and α/β-SNAP required for recycling of SNARE 
complexes at target membranes [111].  Further supporting this idea, measurements of 
STX5a and α/β-SNAP mRNAs by qPCR confirmed that ATF4 contributes to increased 
expression of these ER to Golgi trafficking genes in MEF cells during ER stress (Figure 
3-11D).  These results suggest that the PERK/eIF2~P/ATF4 pathway directs increased 
expression of genes involved in protein trafficking, and highlights the importance of the 
ISR in facilitating ATF6 transport from the ER to the Golgi for cleavage by S1P and S2P.   
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CHAPTER 4.  RESULTS: THE ISR IS REQUIRED FOR ATF5 ACTIVATION  
4.1 CHOP is required for expression transcriptional regulators in the ISR   
 While the ISR activates essential adaptive functions in response to stress, a topic 
of the preceding chapter, unabated induction of these stress responses can contribute to 
morbidity.  Enhanced CHOP expression is one hallmark of this adaptive to maladaptive 
switch which leads to apoptotic cell fate decisions.  Accumulation and sustained levels of 
CHOP are suggested to trigger maladaptive cell fates in response to disruptions in protein 
homeostasis.  With this in mind, we measured CHOP-dependent changes in the 
transcriptome by comparative microarray analysis of WT and CHOP
-/-
 MEF cells upon 
treatment with 1 µM MG132 for 8 hours.  MG132 is a proteasome inhibitor and potent 
pharmacological inducer of eIF2~P and CHOP [107].  8,321 genes as defined by probe 
sets were significantly changed in response to MG132 treatment (Table 4.1.)  Among 
these genes 3,316 (39.8%) were found to be CHOP-dependent, with 46% (1,520 genes) 
enhanced and 54% (1,796 genes) lowered in response to proteasome inhibition.   These 
findings are also illustrated in Figure 4-1A, which features a scatter-plot analysis between 
the stress-induced transcriptome changes in WT cells (x-axis) versus CHOP
-/-
 cells (y-
axis).  The CHOP requirement for changes in the transcriptome is supported by the large 
number of probe sets which were increased in the WT cells upon stress, but induced to a 
lesser extent in CHOP
-/- 
cells.  Pathway analysis of the CHOP-dependent genes was 
performed using IPA analysis to group genes into functional categories.  The top 
functional groups are depicted in Figure 4-1 C where CHOP-dependent gene networks 
were found to be associated with a range of molecular and cellular functions in the 
categories of cell death, cellular growth and proliferation, cell cycle, cellular assembly, 
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organization, and maintenance.  This suggests that although CHOP-dependent genes 
participate in cell death properties they are also found to play a role in a diverse set of 
cellular functions.  Classification of the CHOP-dependent genes by role within the cell 
revealed that CHOP was required for increased expression of HSPA1A and DNAJA4 
involved in protein folding, NOXA, APAF1, and GAS5 involved in cell death, and about 
200 genes involved in regulation of transcription (Figure 4-1B) including MLF1, 
ATF7IP2, and,  ATF5.  The ATF5 transcript was 3.6-fold higher in the WT cells under 
basal conditions and 2-fold higher under stressed conditions when compared to CHOP
-/-
 
cells.  This suggests that CHOP is required for ATF5 mRNA synthesis in both basal and 
stressed conditions.  It was previously reported that ATF5 was subject to preferential 
translation in response to eIF2~P/ATF4 [70], however the transcriptional regulation, 
placement within the ISR pathway, and biological significance was not defined.  The 
characterization of these important aspects of ISR signaling and the CHOP dependent 
regulation of the ATF5 gene will be a focus of this chapter. 
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Table 4-1 CHOP-dependent genes induced by MG132. 
  Fold Change (Treated/Untreated)
a
 
Dependence Total > 1.0 ≥ 2.0 < 1.0 ≤ 0.5 
Total 8h MG132 8321
b
 3607 695 4714 966 
CHOP-dep 8h MG132 
(%) 
3316(39.8)
c
 1520(42.1) 332(47.7) 1796(38.1) 350(36.2) 
a 
Expression profile summary of gene transcripts, as defined by genes that were 
significantly changed after treatment with MG132 (1 µM).  The number of induced genes 
are shown for both the >1.0 fold and ≥ 2.0 fold thresholds.  The repressed genes are also 
shown for the < 1.0 and < 0.5 fold thresholds.   
b The total number of transcripts significantly changed (p ≤ 0.05) by proteasome 
inhibition.   
c 
The number of CHOP-dependent transcripts that were significantly changed by 
proteasome inhibition.   
 
Table 4-2 Functional classification of CHOP specific genes. 
 
Probe IDa Gene name Gene Symbol 
Fold-NT 
(WT/KO)b 
Fold-MG132 
(WT/KO)c 
 TRANSCRIPTION FACTOR    
1417516_at DNA-damage inducible transcript 3 CHOP 2.8 19.5 
1422912_at bone morphogenetic protein 4 BMP4 6.4 14.2 
1416967_at SRY-box containing gene 2 SOX2 9.6 13.9 
1418271_at basic helix-loop-helix family, member e22 BHLHE22 2.8 6.6 
1440275_at runt related transcription factor 3 RUNX3 7.7 4.4 
1421469_a_at signal transducer and activator of transcription 5A STAT5A 3.1 3.4 
1416981_at forkhead box O1 FOXO1 3.7 2.9 
1427938_at c-myc binding protein MYCBP 1.4 2.2 
1425927_a_at activating transcription factor 5 ATF5 3.6 1.8 
1418589_a_at myeloid leukemia factor 1 MLF1 2.1 2.5 
1427603_at activating transcription factor 7 interacting protein 2 ATF7IP2 2.2 6.4 
1448135_at activating transcription factor 4 ATF4 0.7 0.6 
     
 TRANSLATION INITIATION    
1435904_at eukaryotic translation initiation factor 2C, 3 EIF2C3 1.9 1.9 
     
 APOPTOSIS    
1418203_at phorbol-12-myristate-13-acetate-induced protein 1 NOXA 2.5 3.3 
1436222_at growth arrest specific 5 GAS5 2.8 2.1 
1435448_at BCL2-like 11 (apoptosis facilitator) BIM 0.7 1.3 
     
 PHOSPHATASE ACTIVITY    
1429514_at phosphatidic acid phosphatase type 2B PPAP2B 33.7 21.6 
1415834_at dual specificity phosphatase 6 DUSP6 0.5 2.3 
1448325_at myeloid differentiation primary response gene 116 GADD34 1.6 1.4 
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1455728_at phosphatase and tensin homolog PTEN 1.9 1.2 
     
 PROTEIN FOLDING     
1419625_at Heatshock protein 1A HSPA1A 2.7 3.0 
1434196_at DnaJ (Hsp40 homolog, subfamily A, member 4 DNAJA4 1.1 2.7 
1426260_a_at UDP glycosyltransferase 1 family, polypeptide A6 UGT1A6 4.2 7.2 
1455346_at mannan-binding lectin serine peptidase 1 MASP1 3.3 3.7 
     
 CYTOKINE SIGNALLING    
1451798_at interleukin 1 receptor antagonist IL1RN 9.0 12.8 
1417625_s_at chemokine (C-X-C motif) receptor 7 CXCR7 1.9 5.6 
1436861_at interleukin 7 IL7 1.7 2.1 
     
 MISCELLANEOUS    
1421001_a_at carbonic anhydrase 6 CAR6 2.7 24.9 
1436555_at solute carrier family 7, member 2 SLC7A2 3.3 4.5 
1434714_at ERO1-like beta (S.  cerevisiae) ERO1LB 1.7 2.4 
1424048_a_at cytochrome b5 reductase 1 CYB5R1 1.1 1.8 
1418599_at collagen, type XI, alpha 1 COL11A1 5.9 3.9 
1417421_at S100 calcium binding protein A1 S100A1 4.1 3.6 
1443250_at regulator of G-protein signaling 2 RGS2 1.0 1.9 
     
 FATTY ACID SYNTHESIS    
1439478_at acyl-CoA thioesterase 2 ACOT2 2.1 11.5 
1424097_at 
ELOVL family member 7, elongation of long chain 
fatty acids ELOVL7 8.7 7.8 
aAffymetrix Mouse 430 2.0 array, probe set identifier. 
bMean Flourescent intensity fold difference between WT and CHOP-/- cells, No treatment (NT). 
cMean Flourescent intensity fold difference between WT and CHOP-/- cells, MG132 (8 hours). 
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Figure 4-1 Genome-wide analysis of CHOP-dependent genes. 
(A) The scatter plot is the log ratio of stressed versus no stress for WT (x-axis) and 
CHOP
-/-
 MEF cells (y-axis).  This comparative analysis of gene transcripts as defined by 
probe sets (p<0.05) in WT or CHOP
-/-
 MEF cells following treatment with 1 µM MG132 
for 8 hours.  (B) IPA comparison of CHOP-dependent genes classified by functional 
roles.  (C) IPA pie charts highlighting functional classes of CHOP-dependent genes.   
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4.2 CHOP is required for transcriptional expression of ATF5 via binding to CARE 
elements in the ATF5 promoter 
 The importance of CHOP for induced ATF5 mRNA in the ISR was further 
analyzed by using qPCR and RNA prepared from the WT and CHOP
-/-
 cells.  In response 
to treatment with MG132, there was a 1.5-fold increase in ATF5 mRNA levels in WT 
cells, while in CHOP
-/-
 cells the amount of ATF5 transcript was reduced about 50% upon 
proteasome inhibition (Figure 4-2A).  The requirement of CHOP for increased ATF5 
mRNA was also seen when these MEF cells were treated with thapsigargin, which elicits 
ER stress and eIF2~P due to calcium disruption in this organelle (Figure 4-2B).  In wild-
type cells, there was a 4-fold in increase in ATF5 mRNA, which was significantly 
lowered in CHOP
-/- 
cells.  As expected, CHOP mRNA levels were dramatically increased 
in WT cells during either stress arrangement, and there were no detectable CHOP 
transcripts in the CHOP
-/-
 cells (Figures 4-2A and B).  Consistent with earlier reports, we 
found that CHOP was required for full induction of GADD34 mRNA during proteasome 
inhibition (Figure 4-2A) [56].  Supporting the idea that ATF4 is an upstream activator of 
CHOP transcription in the ISR, the amount of ATF4 mRNA was enhanced in WT and 
CHOP
-/-
 cells exposed to MG132 or thapsigargin.  In fact, the ATF4 transcripts were 
further elevated in the stress CHOP-deficient cells (Figure 4-2A and B), suggesting there 
is an extended ISR response with loss of expression of CHOP and its downstream target 
gene GADD34, which facilitates feedback control of the ISR.   Together these results 
indicate that CHOP is required for induced ATF5 mRNAs in response to different stress 
conditions that activate the ISR.      
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Figure 4-2 CHOP is required for enhanced levels of ATF5 mRNA transcripts. 
WT or CHOP
-/-
 MEF cells were treated with 1 µM MG132 (A) or 1µM TG (B) for 8 
hours, and relative levels of ATF4, CHOP, ATF5, and GADD34 mRNAs were 
determined by qPCR.  The “*” represents statistical significance (p<0.05) with respect to 
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the untreated control and the “#” represents a significant difference (p<0.05) between cell 
types.   
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
86 
 
Several potential CHOP binding elements are situated in the ATF5 promoter from 
-2500 to -3000 bp region relative to the ATF5 transcriptional start site.  These binding 
sites termed CARE elements can be placed in either orientation [62, 112], and in the 
ATF5 promoter these were designated CARE-1 (5’-TGATGGAAA-3’) and CARE-2 (5’-
TGATGCAAC-3’) (Figure 4-3A).  We therefore carried out ChIP analyses to measure 
ATF4 and CHOP occupancy on the ATF5 promoter at these CARE sites.  Both CHOP 
and ATF4 were both found to associate with DNA including the CARE-2 element 
(designated P2) in the ATF5 promoter, with significantly enhanced binding in response to 
MG132 (Figure 4-3B), or thapsigargin treatment (Figure 4-3C).  Conversely, there was 
minimal binding of ATF4 and CHOP to the CARE-1 segment (designated P1), which is 
predicted to be a suboptimal CHOP binding site due to a G in the 6
th
 position [113, 114].  
The third site tested is located in an exon (designated P3) and was used as a negative 
control.  As expected, there was minimal ATF4 or CHOP binding at the P3 site in the 
presence of absence of the stresses (Figsure 4-3B and C).  Finally, no signal was detected 
using a non-specific IgG in the ChIP assay (Figure 4-3B).  These results support the idea 
that both CHOP and ATF4 bind directly to the ATF5 promoter to facilitate increased 
transcription in response to diverse stress conditions that elicit the ISR.    
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Figure 4-3 CHOP is required for transcriptional activation of ATF5 by binding to 
CARE elements in the ATF5 promoter.  (A) Diagram of CARE elements found in the 
ATF5 promoter region.  The -2.5 kb and -3.0 kb positions are relative to the 
transcriptional start site.  Cells were treated with MG132 (B), TG (C), or left untreated 
(NT) and Chromatin immunoprecipitation was carried out using antibody for ATF4, 
CHOP or IgG negative control.  qPCR was performed and the enrichment relative to 
input DNA is shown for each of the DNA sites labeled in diagram.  Sites P1 and P2 
contain CARE sequences in the ATF5 promoter, and the site P3 located in exon 3 does 
not contain a CARE site. 
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4.3 CHOP is required for ATF5 protein expression during diverse stress conditions   
 Because ATF5 is also regulated at the level of mRNA translation it was important 
to determine whether CHOP was required for increased ATF5 protein.  WT and CHOP
-/-
 
MEF cells were treated with MG132 for up to 24 hours and the levels of eIF2~P and 
downstream ISR effectors, ATF4 and CHOP proteins, were enhanced early within 1 to 3 
hours of proteasome inhibition (Figure 4-4A).  As expected, no CHOP protein was 
detected in the CHOP
-/-
 cells, whereas induction of ATF4 protein and another ISR 
transcription factor ATF3 was largely unaffected.  While ATF5 protein was increased 
within 3 hours of treatment of WT cells with MG132, there were significantly lowered 
levels of ATF5 in the CHOP
-/-
 cells, with only modest levels of ATF5 protein after 12 
hours of proteasome inhibition.  Stable expression of WT CHOP into the CHOP
-/-
 MEF 
cells significantly enhanced ATF5 proteins upon MG132 treatment (Figure 4-4B).  
Furthermore, we used a lentiviral system and shRNA to stably knockdown CHOP 
expression in mouse liver Hep1-6 cells subjected to proteasome inhibition.  Using clones 
derived from three different validated shRNAs, we found that reduced CHOP levels in 
the Hep1-6 cells led to sharply reduced expression of ATF5 protein upon treatment with 
MG132 (Figure 4-4C).   
Given that eIF2~P and the ISR are induced by many different stress conditions, 
we also addressed whether CHOP facilitates increased ATF5 protein in response to 
treatment with thapsigargin, arsenite, or histidinol (Figure 4-5).  In each stress condition, 
there was a significant diminishment and delay in the induction of ATF5 protein in the 
CHOP
-/-
 cells as compared to WT.  These results support the idea that CHOP is required 
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for full induction of ATF5 expression in the ISR during different stress conditions and in 
multiple cell types.   
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Figure 4-4 CHOP is required for ATF5 protein expression in response to 
proteasome inhibition.  (A) WT and CHOP
-/-
 MEF cells were treated with 1 µM 
MG132 for a time course of up to 24 hours as indicated.  Levels of eIF2α ~P, eIF2α, 
ATF4, CHOP, ATF3, ATF5, caspase-3, parp, and actin were determined by immunoblot 
analysis using antibody specific to the protein of interest.  (B) CHOP
-/-
 cells and CHOP
-/-
  
cells stably expressing a translationally active CHOP from an FRT locus (see materials 
and methods for details) were subjected to up to 24 hours of treatment with 1 µM 
MG132.  Levels of CHOP, ATF5, and actin proteins were determined by immunoblot 
analysis.  (D) HEPA1-6 cells stably expressing a control scrambled shRNA or different 
shRNAs that knocked down CHOP expression were treated with 1µM MG132 for 8 
hours.  The RNA Consortium (TRC) ID# indicates the last two digits in the validated 
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shRNA identification number obtained from Sigma.  Levels of CHOP, ATF5 and actin 
proteins were determined by immunoblot analysis.  (D) WT and CHOP
-/-
 MEF cells were 
exposed to µM MG132 for 24 hours, or not treated (NT).  Cells were then analyzed by 
fluorescence-activated cell sorting (FACS) and Annexin V-FITC/PI staining.   
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Figure 4-5 CHOP is required for ATF5 protein expression in response to diverse 
stress conditions.  WT and CHOP
-/-
 MEF cells were treated with (A) 1 µM thapsigargin 
(TG) or (B) 20 µM arsenite for up to 24 hours, as indicated.  Levels of eIF2~P, eIF2, 
ATF4, CHOP, ATF5, cleaved Caspase-3, cleaved PARP, and actin were determined by 
immunoblot analysis using specific antibodies.  (C) WT and CHOP
-/-
 MEF cells were 
subject to 5 mM histidinol (His-OH) treatment for up to 24 hours.  Levels of CHOP, 
ATF5 and actin proteins were determined by immunoblot analysis.  The “*” indicates an 
un-specified protein recognized by the antibody. 
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4.4 CHOP and ATF5 facilitate apoptosis during proteasome inhibition 
CHOP has a potent pro-apoptotic function in the ISR during extended stress 
arrangements.  This idea is illustrated by the observations that while cleavage of PARP, a 
marker of apoptosis, was present in WT cells following 24 hours of MG132 exposure, 
there was minimal detected cleaved PARP in CHOP
-/-
 cells (Figure 4-4C).  Furthermore, 
cleavage of Caspase 3 was reduced during this stress regimen upon loss of CHOP.  
Consistent with the idea that CHOP can facilitate cell death in response to cellular 
stresses, CHOP
-/-
 cells showed significantly lower levels of apoptosis during MG132 
treatment as compared to WT cells (Figure 4-4D).  Lowered cleaved Caspase 3 and 
PARP were also seen in the CHOP
-/-
 cells upon thapsigargin and arsenite treatments 
(Figure 4.5) supporting the notion that CHOP can signal apoptosis during different 
chronic stresses.   
 Having established that ATF5 expression was dependent on CHOP, the next 
objective was to investigate the role of ATF5 in cell survival during stress.  To achieve 
this goal, lentiviral transduction of shRNA was used to stably knockdown ATF5 in MEF 
cells.  Using a collection of different shRNAs, we were able to achieve 58% to 72% 
knockdown of the ATF5 transcripts compared to no significant difference in knockdown 
in the scramble control (Figure 4-6A).  Two cell lines designated ATF5-KD1 and ATF5-
KD2, with the highest percentage knockdown of ATF5 mRNAs (58% and 72%, 
respectively) were selected for further characterization.  ATF5 protein levels in these 
knockdown cells were also sharply lowered following up to 24 hours of MG132 
treatment (Figure 4-6B).  Supporting the idea that ATF4 and CHOP proteins are upstream 
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activators of ATF5 expression, the levels of ATF4 and CHOP upon exposure to MG132 
were unchanged in WT cells compared to the ATF5 knockdown cells (Figure 4-6B). 
 The role of ATF5 for cell survival was addressed by treating WT and the ATF5 
knockdown cells with a proteasome inhibitor, followed by the MTT assay to measure cell 
viability.  In this experiment WT, CHOP
-/-
, ATF5-KD1, and ATF5-KD2 cells were 
exposed to MG132 for between 1 and 18 hours as outlined in Figure 4-6C.  Following 
each stress time point, fresh media was added with no drug and cells were allowed to 
recover from the stress insult for the remainder of the time course (total 24 hours).  Both 
the ATF5-KD1 and ATF5-KD2 cell lines showed enhanced survival at each time point of 
MG132 compared to WT cells (Figure 4-6D).  The increased survival of the ATF5 
knockdown cells was similar to that determined for CHOP
-/-
 cells.  Furthermore, there 
were significantly lowered levels of cleaved Caspase 3 and PARP in the ATF5-KD1 and 
ATF5-KD2 cells treated with MG132 as compared to WT (Figure 4-6B).  These results 
support the idea that both CHOP and ATF5 facilitate apoptosis during perturbations in 
protein homeostasis.    
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Figure 4-6 ATF5 is required for apoptosis in response to MG132.  (A) RNA was 
isolated from MEF cells stably expressing a scramble shRNA or an ATF5 targeted 
shRNA, ATF5 mRNA levels were determined by qPCR relative to non-shRNA 
expressing control.  Additionally, percentage of ATF5 knockdown was determined 
relative to a non-shRNA expressing control and is also indicated.  (B) WT, ATF5-KD1, 
and ATF5-KD2 MEF cells were treated with the proteasome inhibitor MG132 for the 
96 
 
indicated times.  Levels of ATF4, CHOP, ATF5, cleaved Caspase-9 and Caspase-3, 
cleaved PARP, and actin proteins were measured by immunoblot analysis using antibody 
specific to the protein of interest.  (C and D) Treatment regimen and cell survival as 
determined by MTT assay.  Survival was normalized to the untreated controls for each 
cell type. 
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4.5 ATF5 is required for activation of proapoptotic target genes in response to 
proteasome inhibition   
 To determine the transcriptome changes directed by ATF5 transcription factor, 
and its possible impact in the regulation of apoptosis, we carried out a microarray 
analysis of WT of ATF5-KD2 cells treated with MG132 or no stress.   A total of 8,055 
genes as defined by probe sets were significantly changed in response to MG132 
treatment (Table 4.3).  Among these genes, 3,075 (38%) were dependent on ATF5, with 
1,714 (44%) increased and 1,361 (32%) reduced.   We again utilized IPA software to 
analyze the functional classes of ATF5-dependent genes which are depicted in Figure 4-
7A.  Complete data for this second microarray can be found under the GEO accession 
number GSE4367.  The ATF5-dependent gene network is associated with several 
different functional classes when compared to the networks characterized for CHOP-
dependent genes.  In the ATF5-dependent gene network, we found classes involved with 
infectious disease and inflammatory responses, as well as genes involved in protein 
synthesis, protein degradation, and gene expression (Figure 4-7A).  We compared the set 
of genes requiring ATF5 for full induction with our previous microarray dataset of 
CHOP-dependent genes and found 348 genes (23%) that overlapped in genes dependent 
on both CHOP and ATF5.  Protein folding genes, HSPA1A and DNAJA4 were found to 
be dependent on both CHOP and ATF5.  The transcription factors ATF7IP2 and MLF1, 
and proapoptotic genes GAS5 and NOXA were also noted to be dependent on both CHOP 
and ATF5 for induced expression (Figure 4-7C).  There was also a subset of genes that 
were found to be dependent on ATF5 alone, including APAF1 and TXNIP that are 
involved in apoptosis and the inflammatory response, respectively.  Therefore there are 
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three classes in the ISR-directed transcriptome:  genes that are ATF5-dependent, CHOP-
dependent, and those requiring both transcription factors for full induction in response to 
MG132 treatment.   As noted further below, we have confirmed by qPCR several of the 
key findings in this microarray dataset.  Furthermore we confirmed by qPCR and by 
immunoblot that ATF5 mRNA and protein is depleted in the ATF5-KD2 cells and that 
upstream CHOP expression is unaffected (Figures 4-7A and B).    
 
 
Table 4-3 Number of ATF5 dependent genes induced by MG132. 
 
  Fold Change (Treated/Untreated)
a
 
Dependence Total > 1.0 ≥ 2.0 < 1.0 ≤ 0.5 
Total 8h MG132 8055
b
 3833 69 4222 72 
ATF5-dep 8h MG132 (%) 3075(38.1)
c
 1714(44.7) 52(75.3) 1361(32.2) 41(56.9) 
a 
Expression profile summary of gene transcripts, as defined by genes that were 
significantly changed after treatment with MG132 (1 µM).  The number of induced genes 
are shown for both the >1.0 fold and ≥ 2.0 fold thresholds.  The repressed genes are also 
shown for the < 1.0 and < 0.5 fold thresholds.   
b The total number of transcripts significantly changed (p ≤ 0.05) by proteasome 
inhibition.   
c 
The number of ATF5-dependent transcripts that were significantly changed by 
proteasome inhibition.   
 
99 
 
 
Figure 4-7 Microarray analysis shows ATF5 is required for activation of 
proapoptotic mRNA transcripts in response to ER stress.  (A) IPA analysis of ATF5-
dependent gene networks that highlights functional classes as depicted in the pie charts.  
(B) The numbers of CHOP-only, ATF5-only, and CHOP and ATF5 target genes are 
illustrated in Venn diagrams.  (C)  Comparative bar graph showing the top ATF5-target 
genes, with values representing relative levels of gene transcripts in in mean fluorescent 
intensities (MFI) in WT and ATF5-KD2 cells in the presence or absence of 1 M MG132 
treatment for 8 hours. 
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ATF5 was required for full mRNA induction of several known proapoptotic genes 
including NOXA (PMAIP1), APAF1, and TXNIP (Figure 4-8B).   TXNIP is an example of 
an ATF5-specific gene reported to be involved in apoptosis.  ATF5 was recently reported 
to facilitate increased expression of thioredoxin-interacting protein (TXNIP) during ER 
stress, and knockdown of TXNIP was found to alleviate inflammation and subsequent 
apoptosis in the beta cells [115].  By comparison, induction of GADD34 mRNA in 
response to MG132 was not significantly altered upon knockdown of ATF5, indicating 
that this gene is an example of a CHOP-specific gene that can facilitate apoptosis during 
chronic stress.  NOXA has been previously shown to be important for activation of 
apoptosis in response to ER stress [116].  We found that NOXA mRNA levels were 
increased in an ATF5 and CHOP-dependent fashion in our microarray datasets (Figure 4-
8C and Table 4-2).  Importantly, NOXA transcripts were diminished as judged by qPCR 
in both ATF5-KD1 and ATF5-KD2 cells lines treated with MG132 as compared to WT 
cells.  These results suggest that ATF5 and CHOP are nodes in an ISR transcription 
factor network that participates in the cellular decision to invoke apoptosis during 
extended disruptions in protein homeostasis.   
 
4.6 The ATF5 target gene NOXA is required for increased apoptosis in response to 
proteasome inhibition   
 To address the role of ATF5 and CHOP-target gene NOXA in the regulation of 
cell survival during proteasome inhibition, we utilized shRNA to knockdown NOXA 
mRNA in both MEF and Hepa1-6 cells.  NOXA knockdown was confirmed by qPCR, 
with substantial reductions in NOXA mRNA levels in both of the shRNA expressing cell 
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lines (Figure 4-8A).  The MEF cells depleted for NOXA expression were treated with 
MG132 for 24 hours and found to significantly enhance cell viability, as judged by the 
MTT assay.  The increase in cell viability was comparable to that determined for the 
CHOP
-/- 
cells, further supporting the idea that NOXA is an important target for the ISR 
(Figure 4-8B).  These results support the model that ATF5 is a downstream of CHOP, 
and together these transcription factors can facilitate apoptosis during proteasome 
inhibition.  
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Figure 4-8 Knockdown of NOXA by shRNA protects cells from MG132 stress.   
(A) WT and ATF5-KD2 MEF were treated for 8 hours with 1 M MG132 or subjected to 
no stress treatment.  Levels of CHOP, ATF5, NOXA, TXNIP and APAF1 mRNA were 
quantified by qPCR.  The “*” indicates statistical significance (p<0.05) (B) MEF cells 
expressing an shRNA targeting NOXA, or scramble control, were treated with 1 M 
MG132 for 8 hours.  NOXA mRNA levels were measured by qPCR.  The “*” indicates 
statistical significance (p<0.05).   
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CHAPTER 5.  DISCUSSION 
5.1 ISR signaling is important for cell survival 
Phosphorylation of eIF2 and activation of the ISR are important for signaling 
events that can determine whether a cell survives a stress insult or induces apoptosis.  The 
role of eIF2~P in both outcomes were studied in this thesis.  Results in Chapter 3 focused 
on ISR pathways directing cell survival.  eIF2~P by PERK triggers not only translational 
control in response to ER stress, but also facilitates the activation of ATF6 and the 
transcriptional phase of the UPR.  Among the UPR genes induced by 2-fold, 74% showed 
a significant reduction in gene expression in the LsPERK-KO livers (Table 3-1 and 
Figure 3-3A).  Furthermore, activation of ATF6 in response to ER stress was 
significantly diminished with loss of PERK (Figure 3-4).  These central findings were 
observed not only in liver tissues, but also in MEF cells containing mutations that 
blocked each of the steps in the PERK/eIF2~P/ATF4 pathway (Figures 3-7 and 3-8).   
ATF4 facilitates induction of ATF6 during ER stress by at least two mechanisms.  
First, ATF4 enhances the transcription of the ATF6 gene, ensuring that there are 
sufficient amounts of newly synthesized ATF6 available for continued processing into 
activated ATF6(N) (Figures 3-8 and 3-10).  Second, ATF4 contributes to the trafficking 
of ATF6 from the ER to the Golgi for subsequent proteolysis and activation by S1P and 
S2P.  Supporting this idea is the finding that mutations that adversely affect each step of 
the PERK/eIF2~P/ATF4 pathway significantly diminish the levels of activated ATF6(N) 
in response to either tunicamycin or thapsigargin treatments (Figures 3-7 and 3-8).  By 
comparison, ATF4 is dispensable for the processing of ATF6(N) in MEF cells upon 
exposure with brefeldin A, which triggers redistribution of S1P and S2P to the ER 
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(Figure 3-11B).  This suggests that while S1P and S2P are functional in ATF4
-/-
 cells, the 
passage of ATF6 to the Golgi is impeded with loss of ATF4.  ATF4 contributes to the 
expression of many genes involved in ER to Golgi transport (Figure 3-11, C and D), and 
diminished levels of key proteins that are important for ATF6 trafficking is suggested to 
be an important underlying reason for the reduced activation of ATF6(N) in ATF4-
deficient cells.  These findings provide a mechanistic understanding for earlier reports 
that suggested that PERK may affect the expression of ER chaperones and the efficiency 
of secretory processes [17, 37, 54].  In this regard, this study suggests that ATF4 plays a 
role in the expression of genes contributing to the assembly and processing of secretory 
proteins, in addition to its earlier described role in regulating genes involved in 
metabolism, resistance to oxidative stress, and regulation of apoptosis [40].   
 
5.2 The PERK/eIF2~P/ATF4 pathway alleviates ER stress by multiple mechanisms 
Phosphorylation of eIF2 by PERK directs essential adaptive functions that 
alleviate cellular injury during ER stress.  This is illustrated by our finding that the 
LsPERK-KO livers showed enhanced activation of Caspase-3 and apoptosis during ER 
stress (Figure 3-2).  One underlying mechanism by which PERK can alleviate stress 
damage is by reducing translation, which would lower the influx of nascent proteins into 
the ER organelle that is inundated with misfolded proteins [117].  Our study suggests 
that the PERK/eIF2~P/ATF4 pathway is also central for activation of ATF6 during ER 
stress, and as a consequence is critical for full implementation of the transcription of 
UPR genes, including those involved in protein folding, ERAD, and trafficking in the 
secretory system.  This reconfiguration of the transcriptome would contribute to the 
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expansion of the processing capacity of the secretory pathway, which would be essential 
for returning the stressed ER to homeostasis.  Consistent with these ideas, the livers of 
ATF6
-/-
 mice also showed increased apoptosis when challenged with tunicamycin [26].  
It was suggested that lowered protein chaperone expression in the ATF6-deficient mice 
compromised the ability of the ER to cope with stresses that disrupt protein folding and 
assembly.  Livers from the ATF6
-/-
 mice treated with tunicamycin also exhibited 
significantly more intracellular triglycerides compared with WT, accompanied by 
evidence of microvesicular steatosis [17].  This suggests that perturbations in the hepatic 
lipid homeostasis in the ER-stressed LsPERK-KO mice may result at least in part from 
the failure to appropriately activate ATF6 and its targeted gene expression (Figures 3-3 
and 3-4)   
PERK is also suggested to contribute to cell death during prolonged and severe 
ER stress.  Although the underlying mechanisms by which eIF2~P can contribute to 
apoptosis is not well understood, it is thought that chronic ER stress can induce CHOP 
expression to a certain threshold that induces the expression of genes critical for 
triggering cell death [2, 3].  In this sense, PERK has a dynamic and balanced range of 
cellular responsiveness that is optimal for cellular adaption to ER stress [118].  The 
eIF2~P by PERK would lower protein synthesis and facilitate activation of the UPR, 
which would serve to expand the secretory pathway.  Perturbations in the ISR that lead 
to levels of eIF2~P outside this adaptive zone would trigger extremes in translational 
control that would be detrimental to cells.  For example, hypophosphorylation of eIF2, 
as can be seen in Wolcott-Rallison Syndrome (WRS), can prevent proper 
implementation of UPR transcription, along with heightened protein synthesis, which 
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can exacerbate protein trafficking deficiencies during ER stress.  This can lead to cell 
death by mechanisms independent of CHOP induction [39].  Hyperphosphorylation of 
eIF2 during chronic ER stress can heighten CHOP expression, which is linked to 
signaling pathways that can culminate in apoptosis.    
The range of eIF2~P levels is important to consider when examining the 
biological effects of eIF2~P and the UPR during different stress conditions.  
Chemically-induced ER stress, such as that elicited by tunicamycin used in this study, 
can produce an acute and terminal stress response, whereas physiological stresses that 
the liver can encounter may be more transient and within the adaptive zone [119, 120].   
For example, a high-fat diet can elicit eIF2~P in the liver, and it was reported that 
attenuated eIF2~P in transgenic animals expressing elevated levels of GADD34 can 
diminish liver triglycerides and hepatosteatosis [121].  In this case dephosphorylation 
of eIF2 would be viewed as protective in the liver, while our LsPERK-KO study would 
suggest an important role for the ISR for cellular survival.  The mechanistic rationale 
for these differences is not well understood.  Clearly the expression of important 
regulators of intermediary metabolism, including those involved in lipogenesis and 
lipid oxidation, are affected by the PERK pathway.  The expression of these genes may 
be influenced by the diversity, intensity and duration of the critical stress signals 
triggered by physiological changes in the liver.   
Earlier studies have suggested divergent effects of PERK and IRE1 on cell 
viability [122, 123].  Sustained PERK signaling was proposed to be maladaptive to 
cells, while similar durations of IRE1 activation were suggested to be restricted to 
remedying ER stress.  These ideas are complicated by the findings that PERK is 
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required for full activation of ATF6 and implementation of the UPR transcriptome.  
Furthermore, the PERK/eIF2~P/ATF4 pathway reduced XBP1 expression, although it 
did not appear to alter IRE1 activity as measured by splicing of XBP1 mRNA (Figures 
3-4A).  Therefore, each branch of the UPR is fully integrated, and perturbations of 
PERK can reduce the critical signaling functions required for cell survival during ER 
stress.   
IRE1 is also suggested to be a contributor to apoptosis during certain ER stress 
arrangements.  IRE1 can bind the scaffolding protein TRAF2, which serves to activate 
JNK, a potent inducer of apoptosis [3, 124].  This may be an important underlying 
explanation for the enhanced apoptosis of LsPERK-KO livers during ER stress (Figure 
3-3).  IRE1 dependent JNK signaling is suggested to be significantly enhanced with 
reductions in XBP1 expression [14], and the levels of XBP1 mRNA were significantly 
reduced in LsPERK-KO livers, despite IRE1 endonuclease activity being fully retained 
(Figure 3-4A). 
 
5.3 Role of ATF4 in implementing the UPR 
 ATF4 is suggested to be required for full activation of ATF6 in response to ER 
stress by enhancing ATF6 transcription and by facilitating the expression of genes that 
facilitate ATF6 trafficking from the ER to the Golgi.  ATF4 may carry out these 
functions by directly binding to the promoters of UPR genes, through additional 
transcription factors targeted by ATF4, or by critical cellular changes resulting from 
ATF4-directed transcription.  ATF4-deficient cells are suggested to be defective for the 
expression of genes involved in nutrient import and metabolism that predisposes cells to 
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oxidative stress [40].  This may interfere with cellular processes such as the release of 
ATF6 from the ER, which requires the reduction of disulfide linkages within ATF6 to 
promote deoligomerization required for loading and passage into COPII vesicles for 
anterograde transport to the Golgi [35]. 
 
5.4 ISR signaling is arranged as a binary switch 
 
 Cells recognize and respond to environmental stresses that disrupt protein 
homeostasis.  Depending on the extent and duration of these protein disruptions, stress 
response pathways, such as the ISR, may not be able to restore proteostatic control and 
instead switch to a terminal outcome that features elevated expression of the transcription 
factor CHOP.  The dual nature of the ISR signaling during endoplasmic reticulum stress 
has been referred to as a “binary switch” [12, 13] and the focus of the study presented in 
Chapter 4 was to define the mechanisms by which CHOP directs gene regulatory 
networks that determine these cell fate decisions.  We find that in response to disruption 
of protein homeostasis by proteasome inhibition, CHOP induces the expression of ~200 
transcription regulators, including ATF5 (Figure 4-1, Table 4-2).  Transcriptional 
expression of ATF5 is directly activated by both CHOP and ATF4 (Figure 4-3), 
coincident with the preferential translation of ATF5 during eIF2~P [70].  Like CHOP, 
ATF5 functions to enhance apoptosis during perturbations in protein homeostasis.  
Knockdown of ATF5 expression resulted in improved cell survival in response to 
proteasome inhibition, accompanied by lowered levels of biochemical markers of 
apoptosis (Figure 4-6).  Microarray analysis of ATF5-dependent genes revealed novel 
targets involved in apoptosis (Figure 4-7).  One of these genes, NOXA, was shown to be 
important for inducing cell death during proteasome inhibition (Figure 4-8) [116].  This 
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study indicates that CHOP and the ISR activate a network of transcriptional regulators, 
including ATF5, which function in the binary switch toward apoptosis upon disturbances 
in protein homeostasis.   
 
5.5 The ISR features a network of transcription factors arranged in a feed-forward 
loop 
This study describes three transcriptional factors in the ISR, with a network of 
interactions featuring a feed-forward loop (Figure 5-1) [125].  The transcriptional 
expression of each transcription factor node-ATF4, CHOP, and ATF5 is increased during 
proteasome inhibition.  ATF4 directly enhances CHOP and ATF5 mRNA levels, whereas 
CHOP facilitates the induction of ATF5 transcripts (Figure 5-1).  Currently, we do not 
know the underlying processes by which the transcriptional expression of ATF4 is 
enhanced in the ISR, but eIF2~P is suggested to be a contributing factor [126].  
Accompanying this transcriptional mode of regulation, ATF4, CHOP, and ATF5 mRNAs 
are preferentially translated in response to eIF2~P (Figure 5-1).  Therefore, the activities 
of each transcription factor is tightly linked to eIF2~P levels in the ISR.  With chronic 
disruptions of protein homeostasis there can be high levels of uninterrupted eIF2~P, 
which will amplify the levels of each transcription factor to a proposed threshold that will 
switch the ISR to a terminal outcome.  Added to this ISR amplification, ancillary stress 
response pathways can contribute to the binary switch.  Heterodimerization with other 
bZIP transcription factors, post-translational modifications, and subcellular localization, 
can also contribute to the biological functions of ATF4, CHOP, and ATF5 [84, 104, 127, 
128] 
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Figure 5-1 The ISR network.  Proposed model of ISR signal integration and the ATF4, 
CHOP, and ATF5 network arranged as a feed-forward loop.  Green arrows represent 
eIF2~P dependent translation control.  Blue arrows represent transcriptional control.  
Three groups of genes are presented downstream of the network:  ATF5-dependent, 
CHOP-dependent, and those target genes requiring both ATF5 and CHOP for full 
induction. 
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The network of transcription factors can induce the expression of three classes of 
target genes (Figure 5-1).  The first group is dependent on only the ATF5 transcription 
factor.  Included among the ATF5-specific genes is TXNIP.  Elevated levels of TXNIP 
can dampen the function of thioredoxins, increasing reactive oxygen species (ROS), and 
enhancing caspase-1 cleavage and interleukin-1b production through TXNIP binding to 
the NLRP3 inflammasome, which together can trigger caspase-3 cleavage and cell death 
[115, 129].  It is noted that ATF5 levels are sharply reduced in the absence of CHOP, 
suggesting that the promoters of genes targeted solely by ATF5 would have a higher 
affinity for this transcription factor.  The second group includes CHOP-specific genes, 
exemplified by GADD34, encoding a targeting subunit for Type 1 protein phosphatase 
that can dephosphorylate eIF2~P in a feedback control of the ISR (Figure 5-1) [130, 131].  
CHOP induction of GADD34 expression is suggested to lower cell survival during 
chronic stress, as premature resumption of protein synthesis can lead to further protein 
misfolding and aggregation [56].  The third group contains genes requiring both CHOP 
and ATF5 for full expression (Figure 5-1).  This co-dependence may be the consequence 
of CHOP facilitating elevated expression of ATF5 protein in response to proteasome 
inhibition, aiding the binding of this transcription factor to the promoters of targeted 
genes.  Additionally, CHOP and ATF5 could activate this group of genes by jointly 
associating with their respective promoters.  Included among this third group is NOXA, 
which can induce apoptosis during stresses, such as proteasome inhibition [116, 132-
134].  NOXA is suggested to specifically bind and inhibit BCL2 pro-survival family 
member MCL1, which can facilitate permeabilization of the mitochondrial membrane 
that leads to release of cytochrome C and subsequent activation of the apoptosome 
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complex and cleavage of caspases 3/9.  Additionally, ATF5 facilitates expression of 
APAF1 (Figure 4-8), a key regulator of the apoptosome and apoptosis [135].  Coincident 
with this ATF5-dependent regulation, CHOP can independently repress the 
transcriptional expression of pro-survival BCL2 and enhance that of pro-apoptotic BIM 
(Figure 4-2) [64, 65].  Therefore, CHOP and ATF5 regulate expression of multiple 
regulators of the intrinsic pathway of apoptosis in response to disruptions in protein 
homeostasis, with the overarching theme of induction of pro-apoptotic factors and 
repression of those facilitating survival.   
 
5.6 Biological roles of ATF5   
 Published research on ATF5 has largely focused on its functions in neural 
development and tumorigenesis.  ATF5 mRNA was first detected in sensory neurons 
during embryonic development of the olfactory epithelium and vomeronasal organs, 
suggesting a role for ATF5 in olfactory neuron differentiation [68].  Indeed a recent study 
of mice deleted for ATF5 showed neonatal death due to impaired differentiation and 
survival of olfactory sensory neurons, leading to a competitive suckling defect [136].  
ATF5 was suggested to be directly involved in the transcription of genes important for 
olfactory function, including KIRREL2 and RTP2, by processes that may involve retinoic 
acid.  Neither of these genes was significantly changed in MEF cells in response to 
MG132 treatment, suggesting there are differences between the cell types studied and/or 
stress signals.  ATF5 is also suggested to have a role in the differentiation of other types 
of neuroprogenitor cells, including astrocytes and oligodendrocytes [137-139].   
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 Elevated ATF5 mRNA has also been observed in gliobastomas and other selected 
tumors, and it was suggested that ATF5 expression, which is diminished following neural 
development, can be restored upon cancer differentiation [140].  Genetic disruption of 
ATF5 contributes to survival of glioblastomas and other tumor-derived cell lines, but not 
in corresponding nonneoplastic cell types [141].  These studies suggested that ATF5 is a 
significant contributor to proliferation of certain cancers.  However, in other cell types, 
ATF5 was reported to reduce cell viability.  For example, ectopic expression of ATF5 in 
HeLa cells increased apoptosis upon treatment with cisplatin [128, 142], and ATF4 and 
ATF5 expression in B-cell lymphoma cells treated with the proteasome inhibitor 
bortezomib were associated with increased apoptosis [143].  In this way ATF5 may 
contribute to either cell survival or death depending on the cell type, developmental 
stage, or environmental stress arrangement.   
 We still have much to learn about the networks controlling the expression and 
transcriptional activities of ATF5.  This study indicates that ATF4 and CHOP are 
upstream effectors of ATF5 expression in the ISR, and CHOP and ATF5 can selectively 
target genes that adversely affect cells during proteasome inhibition.  It is noted that basal 
levels of ATF5 mRNA can vary between tissues, with elevated amounts in liver and 
selected neural regions [68].  This would suggest that there are variances in the networks 
that control ATF5 transcript levels among cell types.  Furthermore, there are two ATF5 
mRNAs isoforms that contain identical ATF5 coding sequences, but differ in their 5'-
leader sequences and their mode of translation.  The predominant ATF5α mRNA isoform 
contains a 5'-leader with two uORFs that renders its translation dependent on induced 
eIF2~P [70, 144] whereas the ATF5β transcript contains a 5'-leader derived from another 
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exon and its translation is not suggested to be regulated by stress or eIF2~P [68, 144].  
An important question for future studies is to determine whether eIF2~P and the ISR also 
contributes to ATF5 expression and its functions in cell fate in neural development and in 
proliferation and treatment of cancers. 
 
5.7 Binary switches in biological systems 
 There is room for the binary switch model in the description of complex cellular 
circuitry provided this system is clearly defined before it is applied to a biological 
process.  For example a binary switch model could be used to describe two alternate cell 
fate outcomes (alive/dead) but when used in the process of cell survival or the process of 
cell death further definition is needed.   Figure 5-2 illustrates an example of the cellular 
response to stress.  The y-axis represents the relative level of a given adaptive or 
maladaptive stress responsive effector.  The x-axis is a measurement of stress that could 
be representative of stress duration or dosage.  An inflection point, where the levels of 
adaptive and maladaptive effectors switch is represented by a dotted line dividing the x-
axis.  Contrary to a classic binary switch, it is noted that the adaptive and maladaptive 
effectors are present on both sides of the dotted line and change gradually over time.  
However expressing these effectors as a ratio (maladaptive/adaptive) allows for binary 
quantification where at the inflection point the ratio switches.  Therefore the essence of 
the stress responsive “binary switch” can be defined as the switching from the absence of 
a maladaptive dominant ratio to the presence of maladaptive dominant ratio.   
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Figure 5-2 Stress responses: a binary switch model.  The y-axis shows relative levels 
of stress responsive effectors.  Levels of adaptive stress responsive effectors are shown 
by the green line and levels of maladaptive stress responsive effectors are shown by the 
red line.  The x-axis indicates relative stress measurements that could be represent 
duration or dosage.  The dotted line represents the inflection point where the stress 
response ratio switches from adaptive dominant to maladaptive dominant.    
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